2017-11-03T12:38:38-05:00 2016-12-31 ERNST & YOUNG US LLP 111 MONUMENT CIRCLE SUITE 4000 INDIANAPOLIS IN 46204 990 2016-01-01 912154267 Memorial Sloan-Kettering Cancer Center % MARK K SVENNINGSON MEMO 6462273092 1275 York Avenue New York NY 10065 MARK K SVENNINGSON SVP & CONTROLLER 6462273092 2017-11-03 true JENNIFER D RHODERICK P00395735 3176817000 76.184.247.124 35057220173075000004 2017-11-03 P 7E384602027AAD121D32DED11AC9E3EA31BFD37C C0D8C5AAA40E33188D67D924048345967BDA0662 2016 2017-02-10 21:41:12Z CRAIG B THOMPSON MD 1275 York Avenue New York NY 10065 4532348254 true true 3475 X www.mskcc.org X LEADERSHIP IN THE PREVENTION, TREATMENT, AND CURE OF CANCER THROUGH EXCELLENCE, VISION , AND COST EFFECTIVENESS IN PATIENT CARE, OUTREACH PROGRAMS, RESEARCH, AND EDUCATION. 113 101 18239 943 829849 437797585 484923582 2887464000 3186824175 283282279 67846796 258480850 198554845 3867024714 3938149398 66077484 25038386 0 0 1936724235 2137534438 215653 139618 63193061 1525885369 1618534757 3528902741 3781247199 338121973 156902199 9586730000 9885345175 4055848000 4159357976 5530882000 5725987199 X THE MISSION OF MEMORIAL SLOAN KETTERING CANCER CENTER IS TO LEAD IN THE PREVENTION,DIAGNOSIS,TREATMENT AND CURE OF CANCER AND ASSOCIATED DISEASES THROUGH PROGRAMS OF EXCELLENCE IN RESEARCH, EDUCATION, OUTREACH AND COST-EFFECTIVE PATIENT CARE. LEADERSHIP IN PATIENT CARE: WE PLACE THE HIGHEST PRIORITY ON ADVANCING THE CARE OF CANCER PATIENTS THROUGH EARLY DETECTION, ACCURATE DIAGNOSIS, AND OPTIMAL TREATMENT. THESE THREE ELEMENTS LEAD TO THE MOST EFFECTIVE CANCER CARE POSSIBLE, WHICH IS ALSO THE MOST COST-EFFECTIVE CARE, WE STRIVE FOR EXCELLENCE IN ALL EXISTING AND EMERGING THERAPIES WITHOUT NEGLECTING THE NEED FOR ADVANCED APPROACHES IN PALLIATION. WE DELIVER THESE THERAPIES IN A CARING ENVIRONMENT THAT ENCOMPASSES PATIENTS AS WELL AS THEIR LOVED ONES. EXCELLENCE IN PATIENT CARE IS EXEMPLIFIED BY OUR MULTIDISCIPLINARY APPROACH, A CORE COMPETENCE OF OUR CENTER. WE ARE COMMITTED TO DEVELOPING OUTREACH PROGRAMS TO BRING EXCELLENCE IN CANCER CARE TO THE COMMUNITY. LEADERSHIP IN RESEARCH EXCE false false 3036476932 40969000 3099145175 PATIENT CARE: MEMORIAL SLOAN-KETTERING CANCER CENTER EXPERTS HAVE ESTABLISHED STANDARDS OF CARE AND TREATMENT PROTOCOLS FOR EACH TYPE AND STAGE OF CANCER. OUR PHYSICIANS HAVE AN EXTRAORDINARY DEPTH AND BREADTH OF EXPERIENCE IN DIAGNOSING AND TREATING ALL FORMS OF THE DISEASE, FROM THE MOST COMMON TO THE VERY RARE. EACH YEAR, THEY TREAT MORE THAN 400 DIFFERENT SUBTYPES OF CANCER. THIS LEVEL OF SPECIALIZATION CAN HAVE AN OFTEN-DRAMATIC EFFECT ON A PATIENT'S CHANCES FOR A CURE OR CONTROL OF THEIR CANCER. WHILE WE ARE KNOWN FOR OUR ADVANCED, INNOVATIVE THERAPIES, OUR PHYSICIANS ARE EQUALLY WELL REGARDED FOR THEIR COMPASSION AND CONCERN. OUR DISEASE MANAGEMENT PROGRAM FEATURES 16 MULTIDISCIPLINARY CANCER TEAMS. PATIENTS ARE TREATED BY AS MANY DIFFERENT SPECIALISTS AS ARE NEEDED FOR THEIR PARTICULAR TYPE OF DISEASE, INCLUDING SURGEONS, MEDICAL ONCOLOGISTS, RADIATION ONCOLOGISTS, RADIOLOGISTS, PATHOLOGISTS, PSYCHIATRISTS, AND NURSES. OUR PATHOLOGISTS HAVE UNSURPASSED EXPERTISE IN USING ADVANCED METHODS TO ACCURATELY DIAGNOSE CANCER. BECAUSE OF THEIR SOLE FOCUS ON CANCER, OUR SURGEONS, USE SURGICAL TECHNIQUES THAT PRESERVE FORM AND FUNCTION. OUR RADIATION ONCOLOGISTS ARE DEVELOPING AND PUTTING INTO CLINICAL PRACTICE LEADING-EDGE TECHNOLOGIES AND TECHNIQUES IN RADIATION THERAPY. IN ADDITION, THE CENTER OFFERS A FULL RANGE OF PROGRAMS TO HELP PATIENTS AND FAMILIES THROUGHOUT ALL PHASES OF TREATMENT, INCLUDING SUPPORT GROUPS, GENETIC COUNSELING, HELP MANAGING CANCER PAIN AND SYMPTOMS, REHABILITATION, INTEGRATIVE MEDICINE SERVICES, AND ASSISTANCE IN NAVIGATING LIFE AFTER TREATMENT. 636377629 25897000 87679000 RESEARCH: MEMORIAL SLOAN-KETTERING CANCER CENTER MAINTAINS ONE OF THE WORLD'S MOST DYNAMIC PROGRAMS OF CANCER RESEARCH. THE EXTRAORDINARY PATIENT CARE WE PROVIDE BENEFITS FROM OUR INNOVATIVE PROGRAMS IN BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH. RESEARCH AT SLOAN-KETTERING INSTITUTE IS DEDICATED TO UNDERSTANDING THE BIOLOGY OF CANCER THROUGH PROGRAMS IN CELL BIOLOGY, GENETICS, BIOCHEMISTRY, MOLECULAR BIOLOGY, STRUCTURAL BIOLOGY, COMPUTATIONAL BIOLOGY, IMMUNOLOGY, AND THERAPEUTICS. INVESTIGATORS AT SLOAN-KETTERING INSTITUTE COLLABORATE WITH MEMORIAL HOSPITAL PHYSICIAN-SCIENTISTS, A PARTNERSHIP THAT HELPS SPEED IMPORTANT RESEARCH FINDINGS FROM THE LABORATORY TO THE BEDSIDE, IN A PROCESS KNOWN AS TRANSLATIONAL RESEARCH. MEMORIAL SLOAN-KETTERING CANCER CENTER ALSO ACTIVELY INITIATES AND PARTICIPATES IN CLINICAL TRIALS TO IDENTIFY MORE EFFECTIVE CANCER THERAPIES, AND OUR PHYSICIANS ARE CURRENTLY LEADING 1,072 CLINICAL TRIALS FOR PEDIATRIC AND ADULT CANCERS. THE HUMAN ONCOLOGY AND PATHOGENESIS PROGRAM (HOPP) IS A FURTHER EFFORT TO INCREASE INSTITUTIONAL RESEARCH STRENGTH IN AREAS IMPORTANT IN CONTEMPORARY TRANSLATIONAL RESEARCH. HOPP IS DESIGNED TO MELD EVEN MORE THOROUGHLY THE CULTURES OF BASIC BIOLOGIC SCIENCE AND CLINICAL ONCOLOGY, AUGMENTING THE WORK CONDUCTED IN THE LABORATORIES OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S PHYSICIAN-SCIENTISTS. 3177886 1040000 GRADUATE SCHOOL OF BIOMEDICAL SCIENCE: EDUCATION IS A VITAL PART OF MEMORIAL SLOAN-KETTERING CANCER CENTER'S MISSION. OUR TRAINING PROGRAMS PREPARE PHYSICIANS AND SCIENTISTS FOR CAREERS IN THE BIOMEDICAL SCIENCES. OUR COLLABORATIONS WITH THE ROCKEFELLER UNIVERSITY, CORNELL UNIVERSITY, AND WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY OFFER PHD PROGRAMS IN CHEMICAL BIOLOGY, COMPUTATIONAL BIOLOGY AND MEDICINE, AND THE MEDICAL SCIENCES. THE CENTER ALSO PARTNERS WITH WEILL MEDICAL COLLEGE AND THE ROCKEFELLER UNIVERSITY TO OFFER A MD/PHD DEGREE FOR ASPIRING PHYSICIAN-SCIENTISTS. THE CENTER HAS A PHD PROGRAM IN CANCER BIOLOGY THROUGH ITS LOUIS V. GERSTNER, JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES. THIS NOVEL PROGRAM, HAS BEEN ENROLLING STUDENTS SINCE 2006, TRAINS BASIC LABORATORY SCIENTISTS TO WORK IN RESEARCH AREAS DIRECTLY RELEVANT TO CANCER AND OTHER HUMAN DISEASES. WE ALSO OFFER POSTGRADUATE CLINICAL FELLOWSHIPS TO TRAIN PHYSICIANS WHO SEEK SPECIAL EXPERTISE IN A PARTICULAR TYPE OF CANCER AND POSTGRADUATE RESEARCH FELLOWSHIPS THAT PROVIDE PHYSICIANS AND SCIENTISTS WITH ADVANCED LABORATORY RESEARCH TRAINING. WITH FACULTY APPOINTMENTS AT THE WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY, OUR CLINICAL STAFF ALSO TRAIN RESIDENTS AND MEDICAL STUDENTS. 3676032447 true true false true false false false false false true true true false false true false false true true false true false false true true false true true true true true true false false false false false true false true true true true false false false true true true true false false true 1568 0 true 18239 true true true true LU false false false true true false false false false X 113 101 false false false false true true false true true false false true true true true true true true true true true AK AZ AR FL GA IL KS LA MD MA MI MN MS MO NV NH NJ NM NY ND OH OK PA RI SC TN TX UT WA WI X X MARK K SVENNINGSON 6462273414 633 3RD AVENUE NEW YORK NY 10017 X RICHARD I BEATTIE SEE SCHEDULE O 6.0 0.0 X 0 0 0 ANTHONY B EVNIN SEE SCHEDULE O 3.0 0.0 X 0 0 0 STANLEY F DRUCKENMILLER SEE SCHEDULE O 3.0 0.0 X 0 0 0 RICHARD N FOSTER SEE SCHEDULE O 3.0 0.0 X 0 0 0 STEPHEN FRIEDMAN SEE SCHEDULE O 3.0 0.0 X 0 0 0 ELLEN V FUTTER SEE SCHEDULE O 4.0 0.0 X 0 0 0 LOUIS V GERSTNER JR SEE SCHEDULE O 7.0 0.0 X 0 0 0 JONATHAN N GRAYER SEE SCHEDULE O 3.0 0.0 X 0 0 0 MICHAEL P GUTNICK EXECUTIVE VP & CFO 50.0 0.0 X X 1648988 0 72706 BENJAMIN W HEINEMAN JR SEE SCHEDULE O 3.0 0.0 X 0 0 0 JEFFREY P JOHNSON SEE SCHEDULE O 1.0 0.0 X 0 0 0 VIRGINIA M ROMETTY SEE SCHEDULE O 3.0 0.0 X 0 0 0 DAVID H KOCH SEE SCHEDULE O 4.0 0.0 X 0 0 0 MARIE-JOSEE KRAVIS SEE SCHEDULE O 4.0 0.0 X 0 0 0 PETER J SOLOMON SEE SCHEDULE O 3.0 0.0 X 0 0 0 PETER A WEINBERG SEE SCHEDULE O 2.0 0.0 X 0 0 0 JAMES G NIVEN SEE SCHEDULE O 5.0 0.0 X 0 0 0 ROGER W FERGUSON SEE SCHEDULE O 3.0 0.0 X 0 0 0 BRUCE C RATNER SEE SCHEDULE O 3.0 0.0 X 0 0 0 CLIFTON S ROBBINS SEE SCHEDULE O 7.0 0.0 X X 0 0 0 JAMES D ROBINSON III SEE SCHEDULE O 4.0 0.0 X 0 0 0 ALEXANDER T ROBERTSON SEE SCHEDULE O 3.0 0.0 X 0 0 0 NORMAN C SELBY SEE SCHEDULE O 6.0 0.0 X X 0 0 0 STEPHEN C SHERRILL SEE SCHEDULE O 5.0 0.0 X 0 0 0 SCOTT M STUART SEE SCHEDULE O 6.0 0.0 X 0 0 0 MARK SVENNINGSON SVP FINANCE & CONTROLLER 50.0 0.0 X X 879585 0 81370 DOUGLAS WARNER III SEE SCHEDULE O 8.0 0.0 X X 0 0 0 DEBORAH C WRIGHT SEE SCHEDULE O 3.0 0.0 X 0 0 0 KATHRYN MARTIN CHIEF OPERATING OFFICER 50.0 0.0 X X 1738256 0 81313 CRAIG B THOMPSON MD PRESIDENT & CEO 50.0 0.0 X X 5337371 0 1381832 JOSE BASELGA MD PHD PIC & CHIEF MEDICAL OFFICER 50.0 0.0 X X 1564943 0 82273 WILLIAM E FORD SEE SCHEDULE O 3.0 0.0 X 0 0 0 JAMIE C NICHOLLS SEE SCHEDULE O 3.0 0.0 X 0 0 0 LAVINIA BRANCA SNYDER SEE SCHEDULE O 3.0 0.0 X 0 0 0 IAN COOK SEE SCHEDULE O 3.0 0.0 X 0 0 0 JOHN R STRANGFELD SEE SCHEDULE O 3.0 0.0 X 0 0 0 ERIC M COTTINGTON PHD SVP RESEARCH & TECHNOLOGY MGMT 50.0 0.0 X 885023 0 76996 JASON KLEIN SVP-CHIEF INVESTMENT OFFICER 50.0 0.0 X 2811422 0 1592843 EDWARD MAHONEY SVP FACILITIES MGMT & CONST 50.0 0.0 X 1561293 0 68033 RICHARD K NAUM SVP DEVELOPMENT 50.0 0.0 X 683152 0 77535 PATRICIA C SKARULIS SVP-CHIEF INFORMATION OFFICER 50.0 0.0 X 958884 0 54805 SIMON N POWELL MD CHAIR & ATTEND RAD ONCOLOGY 50.0 0.0 X 1716568 0 63542 CAROLYN B LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 50.0 0.0 X 486571 0 38518 KERRY BESSEY SVP & CHIEF HR OFFICER 50.0 0.0 X 896440 0 68804 AVICE MEEHAN SVP CH COMMUNICATION OFFICER 50.0 0.0 X 605954 0 54906 EDWIN TALIAFERRO VP INTERNAL AUDIT & COMPLIANCE 50.0 0.0 X 512126 0 50236 FREDRICK GROVES EVP & HOSPITAL ADMINISTRATOR 50.0 0.0 X 577063 0 29901 JORGE LOPEZ EVP GENERAL COUNSEL 50.0 0.0 X 545347 0 47236 KENNETH MARIANS PHD DEAN, GERSTNER GRADUATE SCHOOL 50.0 0.0 X 555978 0 77079 ANNE MCSWEENEY SPECIAL ADVISOR TO PRESIDENT 50.0 0.0 X 1307735 0 72180 RICHARD BARAKAT MD DPIC-REGIONAL CARE NETWORK 50.0 0.0 X 1172075 0 76008 PAUL SABBATINI MD DPIC CLINICAL RESEARCH 50.0 0.0 X 750394 0 55885 ELIZABETH MCCORMICK MSNRN SVP & CH NURSING OFFICER 50.0 0.0 X 631943 0 54890 CYNTHIA MCCOLLUM SVP HOSPITAL OPERATIONS 50.0 0.0 X 602925 0 64785 MARGARET BURKE SVP AMBULATORY CARE-HOSP OPS 50.0 0.0 X 670057 0 77046 JOAN MASSAGUE PHD DIRECTOR, SLOAN KETTERING INST 50.0 0.0 X 1321196 0 52386 EPHRAIM CASPER MD MEDICAL DIRECTOR-REGIONALS 50.0 0.0 X 868921 0 583150 ELIZABETH HERBERT SVP, HOSPITAL ADMINISTRATION 50.0 0.0 X 586324 0 73130 PETER T SCARDINO MD CHAIRMAN & ATTENDING SURGERY 50.0 0.0 X 2695019 0 95502 PHILIP GUTIN MD CHAIR & ATTENDING NEUROSURGERY 50.0 0.0 X 2746988 0 54266 JOSEPH DISA MD ATTENDING PLASTIC SURGERY 50.0 0.0 X 1606398 0 74289 MARK BILSKY MD ATTENDING-DEPT OF NEUROSURGERY 50.0 0.0 X 1706522 0 366412 BABAK MEHRARA MD Chief Attending-Surgery 50.0 0.0 X 1587642 0 67301 JOHN R GUNN 2015 FORMER COO 0.0 0.0 X 229167 0 0 THOMAS KELLY MD FORMER DIRECTOR S.K.I 50.0 0.0 X 556782 0 74713 ROGER PARKER ESQ EVP & GENERAL COUNSEL 50.0 0.0 X 642932 0 29555 43647984 0 5871426 5001 true true false TURNER CONSTRUCTION 375 HUDSON STREET NEW YORK NY 10014 GENERAL CONSTRUCTION 227973293 HUNTER ROBERTS CONSTRUCTION GR LLC 2 WORLD FINANCIAL CENTER NEW YORK NY 10001 GENERAL CONSTRUCTION 70764535 JGN CONSTRUCTION CORP 66-40 69TH STREET MIDDLE VILLAGE NY 11379 GENERAL CONSTRUCTION 24228039 PERKINS EASTMAN ARCHITECTS 115 FIFTH AVENUE NEW YORK NY 10003 ARCHITECURAL 9568831 WM BLANCHARD 199 MOUNTAIN AVENUE SPRINGFIELD NJ 07081 GENERAL CONSTRUCTION 7773701 178 1074953 161721000 322127629 21944904 484923582 MEDICAL CARE 622310 3099145175 3099145175 NON-GOVERNMENT SPONSORED RESEARCH 541711 87679000 87679000 3186824175 25639796 1958698 23681098 8557000 8557000 167731000 167731000 37210000 40997634 -3787634 0 -3787634 -3787634 585978283 552328283 33650000 33650000 33650000 2559418 1074953 872939 1686479 1686479 0 0 0 0 0 0 CAFETERIA 722212 5317000 5317000 VENDOR DISCOUNTS 561439 1451000 1451000 SERVICES PROVIDED 561439 6013000 6013000 20144000 -1128849 21272849 32925000 3938149398 3186824175 829849 265571792 1100000 1100000 23938386 23938386 0 0 37493489 28709499 6643388 2140602 1799581 1570414 229167 1630192346 1602789070 6584019 20819257 134096717 132133673 521975 1441069 236248272 229058617 3464374 3725281 97704033 95702082 617789 1384162 0 15468985 14572827 701082 195076 807313 690350 116369 594 896016 896016 139618 139618 7886480 7886480 72964682 66936952 2829553 3198177 17540754 16308938 1231816 256365801 230662158 2168619 23535024 28582814 28204035 118788 259991 5823820 5823820 113398855 102221902 10022413 1154540 10587568 9690034 305544 591990 0 11011328 9885241 353940 772147 48723848 48294003 429845 0 263964341 260323183 2743212 897946 26173193 25886441 173977 112775 PHARMACEUTICALS 550596141 550596141 MEDICAL/SURGICAL SUPPLIES 194536701 194111865 424836 PROVISION BAD DEBT-REG ASSMT 35002967 35002967 UBIT EXPENSE 73723 73723 -41870573 -33252347 -10211222 1592996 3781247199 3676032447 42021691 63193061 X 16344917 8282854 8062063 304373000 456756000 360913000 419984000 692114000 597945000 470238000 451937175 1245503 1100000 0 0 29292497 31609000 53964000 56919000 101110000 99389000 6002619000 2643271000 3013201000 3359348000 3694224000 3597777000 846022000 792425000 20033000 20156000 0 0 0 0 9586730000 9885345175 674852000 728200976 0 0 0 0 1551075000 1265956000 0 0 0 0 0 0 973060000 1350000000 856861000 815201000 4055848000 4159357976 X 4191801000 4341317199 734851000 757725000 604230000 626945000 5530882000 5725987199 9586730000 9885345175 X 156902199 118923000 -80720000 X false true X true true true X 3 SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 131624182 4 true 0 0 MEMORIAL HOSPITAL FOR CANCER & ALLIED DISEASES 131624082 3 true 0 0 MEMORIAL SLOAN-KETTERING CANCER CENTER 131924236 3 true 0 0 3 386914750 537706930 544924247 437479585 484699242 2391724754 0 0 386914750 537706930 544924247 437479585 484699242 2391724754 120670784 2271053970 123868692 135524730 210605148 245714279 201917796 917630645 0 0 3309355399 13618746307 0.68625 0.70145 X false false false false false 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 SUPPORTED ORGANIZATIONS SUPPORT FROM THE SUPPORTING ORGANIZATIONS RELATE PRINCIPALLY TO THE SHARING OF CERTAIN FACILITIES, EQUIPMENT, PERSONNEL COSTS, EDUCATION, INSURANCE AND ALLOCATIONS. AMOUNTS DUE TO OR DUE FROM AFFILIATES RESULTING FROM THESE SERVICES DO NOT BEAR INTEREST. SUPPORTING ORGANIZATIONS NAME OF SUPPORTING ORGANIZATION EIN TYPE S.K.I. REALTY 13-3389586 11a LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES 20-2212588 11a MSK INSURANCE US 83-0363317 11a MSKCC PROTON INC. 35-2397819 11a MSKCC PROPERTIES, LLC. 35-2464610 11a RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false true false false false false true 609475 false true 286541 896016 false LOBBYING COSTS MSKCC ENGAGES IN BOTH FEDERAL, STATE AND LOCAL LOBBYING. THE CENTER'S FEDERAL LOBBYING EFFORT FOCUSES ON PATIENT CARE AND REIMBURSEMENT ISSUES. PATIENT CARE ADVOCACY INCLUDES ENSURING PATIENTS ARE ABLE TO ACCESS CLINICAL TRIALS AND CANCER HOSPITALS ARE ABLE TO EFFECTIVELY RESEARCH POTENTIAL TREATMENTS FOR CANCER AS WELL AS PREVENTIVE AND PALLIATIVE MEASURES. THE CENTER ALSO SEEKS TO RECEIVE EQUITABLE REIMBURSEMENT FOR SERVICES RENDERED TO PATIENTS ENROLLED IN ENTITLEMENT PROGRAMS. FROM TIME TO TIME THE CENTER WEIGHS IN ON OTHER FEDERAL LEGISLATION THAT IMPACTS CANCER CARE AND HOSPITALS IN GENERAL. THE CENTER'S STATE LOBBYING EFFORT CONCENTRATES ON LEGISLATION THAT IMPACTS PROVIDERS' ABILITIES TO EFFECTIVELY CARE FOR PATIENTS, SUCH AS LEGISLATION THAT AMENDS CONSTRUCTION REVIEW PROCEDURES, PROVIDES FUNDING FOR BLOOD DONATION DRIVES, OR ENCOURAGES COLLABORATION BETWEEN CARE PROVIDERS AT HOSPITAL FACILITIES. STATE EFFORTS ALSO FOCUS ON ADVOCATING FOR HEALTH CARE ISSUES DURING STATE BUDGET NEGOTIATIONS. LOCAL LOBBYING IS PERFORMED BY THE GREATER NEW YORK HOSPITAL ASSOCIATION ON BEHALF OF ITS MEMBERS. PART II-B LINE 1I OTHER ACTIVIES LOBBYING PORTION OF DUES PAID IN 2016: AMERICAN HOSPITAL ASSOCIATION $ 29,237 GREATER NEW YORK HOSPITAL ASSOCIATION $257,304 TOTAL $286,541 false false 778565000 18986000 5197000 802748000 772740000 17561000 -2097000 9639000 778565000 753249000 25760000 9616000 15885000 772740000 709754000 56687000 44303000 57495000 753249000 726867000 24401000 10195000 51709000 709754000 0.21900 0.78100 true true true 380703000 380703000 4073948000 1514999000 2558949000 99657000 56186000 43471000 1448311000 1072086000 376225000 3359348000 PRIVATE EQUITY & VENTURE CAP. 756852000 F NONMARKETABLE SECURITIES 35573000 C 792425000 0 PENSION AND POSTRETIREMENT 399381000 INSURANCE RESERVES 285197000 DEFERRED COMPENSATION 62030000 ASSET RETIREMENT OBLIGATIONS 38374000 DEFERRED GIFT ANNUITY 22458000 OTHER LIABILITIES 7761000 815201000 4079043175 118923000 41870573 160793573 3918249602 19899796 19899796 3938149398 3802117976 41870573 41870573 3760247403 19899796 1100000 20999796 3781247199 USE OF ENDOWMENT FUNDS PERMANENT ENDOWMENT FUNDS ARE HELD BY THE ORGANIZATION IN PERPETUITY. INCOME EARNED ON THE FUND BALANCE IS USED TO SUPPORT THE OPERATIONS OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. OTHER PARTS XI AND XII LINE 2D COSTS ARE REMOVED FROM THE STATEMENT OF FUNCTIONAL EXPENSES AND NETTED ON THE STATEMENT OF REVENUE AS FOLLOWS: RENTAL EXPENSES $40,997,634 FUNDRAISING COSTS 872,939 TOTAL $41,870,573 PART XII LINE 4B PAYMENT OF A GRANT TO THE RALPH LAUREN CENTER FOR $1,100,000 RECORDED AS NON OPERATING EXPENSE. FIN 48 LIABILITY FOR UNCERTAIN TAX POSITIONS A FIN 48 FOOTNOTE DISCLOSURE, RELATING TO THE ACCOUNTING FOR INCOME TAXES, WAS NOT REQUIRED BECAUSE THERE WAS NO MATERIAL IMPACT ON THE INSTITUTION'S FINANCIAL STATEMENTS. true true true true true true true false false false false false false false false false false true NONDISCRIMINATORY POLICY THE SCHOOL'S NONDISCRIMINATORY POLICY IS PUBLICIZED ON ITS WEB SITE: HTTP://WWW.SLOANKETTERING.EDU/GERSTNER/HTML/54499.CFM. ALL APPLICANTS TO THE LOUIS V. GERSTNER JR., GRADUATE SCHOOL OF BIOMEDICAL SCIENCES ARE CONSIDERED ON THE BASIS OF MERIT. THE SCHOOL DOES NOT DISCRIMINATE ON THE BASIS OF GENDER, RACE, COLOR, CREED, RELIGION, AGE, NATIONAL ORIGIN, DISABILITY, VETERAN STATUS, MARITAL STATUS, SEXUAL ORIENTATION, OR CITIZENSHIP STATUS IN ACCORDANCE WITH INSTITUTIONAL POLICY AND IN COMPLIANCE WITH THE REQUIREMENTS OF THE CIVIL RIGHTS ACT, THE EDUCATION ADMENDMENTS, THE REHABILITATION ACT, THE AGE DISCRIMINATION ACT, AND THE AMERICANS WITH DISABILITIES ACT. East Asia and the Pacific Program Services PATIENT CARE CONFRENCE 176603 Europe (Including Iceland and Greenland) Program Services PATIENT CARE CONFRENCE 881734 Middle East and North Africa Program Services PATIENT CARE CONFRENCE 94764 North America Program Services PATIENT CARE CONFRENCE 137014 South America Program Services PATIENT CARE CONFRENCE 40731 South Asia Program Services PATIENT CARE CONFRENCE 20017 Sub-Saharan Africa Program Services PATIENT CARE CONFRENCE 20234 East Asia and the Pacific Program Services RESEARCH CONFRENCES 186368 Europe (Including Iceland and Greenland) Program Services RESEARCH CONFRENCES 496149 Middle East and North Africa Program Services RESEARCH CONFRENCES 48951 North America Program Services RESEARCH CONFRENCES 53665 South America Program Services RESEARCH CONFRENCES 10364 South Asia Program Services RESEARCH CONFRENCES 9372 East Asia and the Pacific Program Services INVESTMENT MEETINGS 41827 Europe (Including Iceland and Greenland) Program Services INVESTMENT MEETINGS 87251 North America Program Services INVESTMENT MEETINGS 10173 Central America and the Caribbean Investments 1298810165 Europe (Including Iceland and Greenland) Investments 82999876 Sub-Saharan Africa Investments 1687865 1301125382 84687741 1385813123 true false true true true false ORGANIZATION'S PROCEDURES FOR THE USE OF FUNDS OUTSIDE THE US MEMORIAL SLOAN-KETTERING CANCER CENTER DOES NOT MAKE GRANTS OR USE GRANT MONEY OUTSIDE OF THE UNITED STATES. INVESTMENTS BY REGION VALUES SHOWN IN COLUMN F ARE THE MARKET VALUES FOR THE INVESTMENTS AT DECEMBER 31. X X X X X X X true DONOR SERVICES 6715 SUNSET BLVD HOLLYWOOD CA 90028 TELEMARKETI false 686072 139618 546454 686072 139618 546454 All States SPRING BALL 1348285 237324 1110961 104246 27600 89730 FALL PARTY 521844 257844 264000 72010 5000 55752 5 1764242 579785 1184457 94932 219820 13575 190274 3634371 1074953 2559418 94932 396076 46175 335756 872939 1686479 true true X true X 500. true X 500. true true true false true true 20322610 2926194 17396416 0.00460 190555622 80320160 110235462 0.02940 210878232 83246354 127631878 0.03400 20007758 20007758 0.00530 188327552 13389892 174937660 0.04660 2894479 2894479 0.00080 426086926 169422000 256664926 0.06830 1305164 1305164 0.00030 638621879 182811892 455809987 0.12130 849500111 266058246 583441865 0.15530 28926 28926 187639 9475 178164 0.00010 161640 161640 143182 143182 521387 9475 511912 0.00010 false 69861175 2762669 841808797 1023288865 -181480068 X true true 1 1 MEMORIAL HOSP FOR CANCER & ALLIED DIS 1275 YORK AVENUE NEW YORK NY 10065 www.mskcc.org 7002020H X X X X MEMORIAL HOSP FOR CANCER & ALLIED DIS 1 false false true X X X X X X X X X X 16 true false false true X www.mskcc.org/communityserviceplans X true 16 true www.mskcc.org/communityserviceplans false true X 500. 500. X X X X X X true true X X X X true X SEE SCH H, PART V, SECTION C X www.mskcc.org/financial-assistance X SEE SCH H, PART V, SECTION C X X X X X true X false X X X true X false false PART V FACILITY INFORMATION FACILITY POLICIES AND PRACTICES LINE 3 MSKCC CONDUCTED A COMMUNITY HEALTH NEEDS ASSESSMENT IN THE FALL OF 2016 TO DETERMINE THE CRITICAL CANCER-RELATED HEALTH CONCERNS FACING RESIDENTS IN OUR 23-COUNTY CATCHMENT AREA IN NEW YORK, NEW JERSEY, AND CONNECTICUT. WE ANALYZED CANCER STATISTICS ON INCIDENCE, PREVALENCE, AND MORTALITY. WE ALSO REVIEWED KEY HEALTH TRENDS AMONG CANCER PATIENTS, MULTICULTURAL POPULATIONS AND THE GENERAL PUBLIC. LINE 5 TO ENGAGE THE BROAD COMMUNITY IN OUR HEALTH NEEDS ASSESSMENT, MSKCC HELD A SERIES OF COMMUNITY FORUMS IN HARLEM, BROOKLYN, AND MANHATTAN, TO CONNECT WITH REPRESENTATIVES FROM COMMUNITY-BASED ORGANIZATIONS THAT SERVE CLIENTS THROUGHOUT NEW YORK CITY AND ITS SURROUNDING COMMUNITIES. REPRESENTATIVES FROM 22 COMMUNITY BASED ORGANIZATIONS PARTICIPATED IN THE FORUMS AND SERVE A DIVERSE RANGE OF CLIENTS. SERVICES PROVIDED BY THESE ORGANIZATIONS INCLUDE CANCER SUPPORT SERVICES, DOMESTIC VIOLENCE SUPPORT, IMMIGRATION ASSISTANCE, AND PRIMARY CARE SERVICES. COMMUNITY ORGANIZATIONS THAT PROVIDED INPUT ON MSKCC'S NEEDS ASSESSMENT INCLUDE: AMERICAN CANCER SOCIETY ARAB AMERICAN FAMILY SUPPORT CENTER BRONX HEALTH REACH BROOKLYN COMMUNITY SERVICES CANCER AND CAREERS CANCER CARE COALICION MEXICANA QUEENS LIBRARY THE CREATIVE CENTER FRIENDS OF KAREN GILDAS CLUB HARLEM UNITED MAKE THE ROAD NEW YORK SHARE MEXICAN CONSULATE NATIONAL OVARIAN CANCER COALITION COMMUNITY ACTION NETWORK HEALTHY START BROOKLYN NEW YORK CITY DEPARTMENT OF HEALTH & MENTAL HYGIENE NEW YORK CITY FAMILY JUSTICE CENTER THE LEUKEMIA & LYMPHOMA SOCIETY LINE 7D SUMMARY FINDINGS OF MSKCC'S CHNA WERE SENT TO COMMUNITY BASE ORGANIZATIONS WITH WHOM WE WORK AND WERE ALSO INCORPORATED INTO OUR ANNUAL COMMUNITY SERVICE PLAN REPORT. THE COMMUNITY SERVICE PLAN (CSP) IS DISTRIBUTED TO LOCAL ELECTED OFFICIALS, ORGANIZATIONS, AND IS AVAILABLE TO THE PUBLIC AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. THE CHNA WAS ALSO PUBLICIZED THROUGH OUR COMMUNITY NEWSLETTERS WHICH ARE DISTRIBUTED TO APPROXIMATELY 50,000 RESIDENTS NEAR OUR TREATMENT FACILITIES. LINE 11 THE CHNA FOUND THAT MSKCC IS CURRENTLY ADDRESSING MANY AREAS OF NEED INCLUDING COLLABORATIVE INITIATIVES, FINANCIAL INFORMATION/ASSISTANCE, PREVENTION PROGRAMS, TRANSPORTATION AND PATIENT NAVIGATION. IN ADDITION, MSKCC HAS IDENTIFIED SOME NEW AREAS OF FOCUS AS A RESULT OF THE CHNA. THESE INCLUDE: KNOWLEDGE GATHERING AND NEW PROGRAMMING TO REACH MULTICULTURAL POPULATIONS SPECIFICALLY TARGETED TO THE HISPANIC POPULATION IN OUR SERVICE AREA; ENHANCED COLLABORATIONS WITH COMMUNITY BASED ASSOCIATIONS; FINANCIAL ASSISTANCE AWARENESS; CANCER SCREENING AMONG UNDERSERVED POPULATIONS; INCREASE PARTICIPATION IN MSKCCS SMOKING CESSATION SERVICES; AND EDUCATIONAL MATERIALS FOR MULTICULTURAL AUDIENCES IN SPANISH AND RUSSIAN. ADDITIONAL INFORMATION ON IDENTIFIED NEEDS AND WHAT NEEDS ARE NOT BEING ADDRESSED TOGETHER WITH THE REASON WHY SUCH NEEDS ARE NOT BEING ADDRESSED CAN BE FOUND IN THE HOSPITALS MOST RECENT COMPREHENSIVE THREE-YEAR CSP AND CHNA REPORT POSTED AT WWW.MSKCC.ORG/COMMUNITYSERVICEPLANS. IDENTIFIED NEEDS THAT MSKCC CANNOT ADDRESS ADEQUATELY BECAUSE THEY ARE BEYOND OUR SCOPE OF SERVICE ARE; LEGAL ADVOCACY, POLITICAL ADVOCACY, AND SUPPORT SERVICES FOR CRISIS INTERVENTION. WITHIN THESE CONSTRAINTS, MSKCC PROVIDES REFERRALS TO EXTERNAL ORGANIZATIONS THAT RESPOND TO THESE NEEDS. LINE 13G NEW PATIENTS WHO RESIDE IN NEW YORK OR NEW JERSEY MAY QUALIFY FOR AID. EXISTING PATIENTS MAY QUALIFY FOR AID REGARDLESS OF WHERE THEY LIVE IN THE UNITED STATES. LINE 15E FOR MANY YEARS MSKCC HAS PROVIDED FINANCIAL HELP TO PATIENTS IN NEED. OUR FINANCIAL ASSISTANCE PROGRAM AIDS UNINSURED AND UNDERINSURED PATIENTS WITH HOUSEHOLD INCOME UP TO FIVE TIMES THE FEDERAL POVERTY LEVEL WHO CANNOT GET PUBLICLY FUNDED HEALTH INSURANCE OR CANNOT AFFORD TO PAY FOR THEIR MEDICAL CARE. TO BE CONSIDERED FOR THE FINANCIAL ASSISTANCE PROGRAM, PATIENTS ARE ASKED TO PROVIDE CERTAIN PERTINENT DOCUMENTATION TO ASSIST IN DETERMINING THEIR ELIGIBILITY AND THE AMOUNT OF FINANCIAL ASSISTANCE THEY ARE QUALIFIED TO RECEIVE. TO FURTHER ENHANCE THE PROCESS, WE STRATEGICALLY PLACE FINANCIAL ASSISTANCE BROCHURES AT EACH REGISTRATION SITE AND AT THE FRONT DESK OF PATIENT FINANCIAL SERVICES OFFICE. WE INCLUDE COPIES WITH THE FIRST AND EACH SUBSEQUENT HOSPITAL BILL SENT TO PATIENTS AND WITH COLLECTIONS LETTERS MAILED OUT TO THEM. ADDITIONALLY, THE FINANCIAL ASSISTANCE INFORMATION IS POSTED ON THE MSKCC WEBSITE AT WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE. LINE 16 THE FAP, FAP APPLICATION, AND THE PLAIN LANGUAGE SUMMARY WERE WIDELY AVAILABLE ON THE ORGANIZATION'S WEBSITE AT:WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE. LINE 20 MSKCC DOES NOT PURSUE ANY EXTRAORDINARY COLLECTION ACTIONS, HOWEVER, PRIOR TO REFERRING A PATIENT ACCOUNT TO A COLLECTION AGENCY MSKCC SENDS THE FAP BROCHURE WITH THE INITIAL HOSPITAL BILL TO EVERY NEW PATIENT TO MAKE THEM AWARE OF THE CHARITY CARE/FINANCIAL ASSISTANCE PROGRAM. THE FAP IS MENTIONED ON EVERY PATIENT STATEMENT AND LETTER THAT IS SENT TO A PATIENT. THE FAP IS ALSO MENTIONED ON EVERY COLLECTION LETTER SENT TO PATIENTS BY THE COLLECTION AGENCIES. EVEN AFTER A PATIENT ACCOUNT IS SENT TO COLLECTIONS HE/SHE CAN STILL APPLY FOR FINANCIAL ASSISTANCE. IT IS NEVER TOO LATE TO APPLY FOR FINANCIAL ASSISTANCE AND IF ELIGIBLE RETRO ACTIVE FAP COVERAGE WOULD BE GIVEN. LINE 21D ALL OF OUR PATIENTS REQUIRING URGENT CARE ARE PROVIDED WITH THE SERVICE REGARDLESS OF THEIR INSURANCE AND/OR FINANCIAL LIMITATION. FURTHERMORE,SERVICES ARE PROVIDED EVEN IF A DETERMINATION REGARDING ELIGIBILITY FOR MSKCC'S FAP HAS NOT YET BEEN MADE. LINE 22D THE MAXIMUM AMOUNT CHARGED TO PATIENTS DEEMED ELIGIBLE FOR FAP "FOR EMERGENCY OR OTHER MEDICALLY NECESSARY CARE" IS THE AMOUNT WE INITIALLY CONCLUDE A PATIENT CAN AFFORD TO PAY WHEN FINALIZING THEIR FAP APPLICATION. THIS AMOUNT IS DERIVED BY CALCULATING A PATIENTS HOUSEHOLD NET MONTHLY INCOME AND THEN DEDUCTING THE TOTAL AMOUNT OF THEIR ROUTINE MONTHLY BILLS. THE AMOUNT REMAINING IS WHAT WE CONSIDER THE PATIENT IS ABLE TO AFFORD TO PAY EACH MONTH. IF THE PATIENTS HOUSEHOLD ROUTINE MONTHLY BILLS ARE MORE THAN OR EQUAL TO THEIR NET MONTHLY INCOME, WE WOULD ACCEPT WHATEVER THE PATIENTS INSURANCE PAYS AS PAYMENT IN FULL, (THE PATIENT WOULD NOT HAVE TO PAY ANYTHING OUT OF POCKET) UNLESS THE PATIENT HAS ASSETS SUCH AS A SECOND HOME, STOCKS, CERTIFICATES OF DEPOSITS, LARGE SAVINGS OR ANY OTHER ASSETS EXCLUDING RETIREMENT AND EDUCATION ACCOUNTS. PATIENTS WITH LARGE AMOUNTS OF ASSETS WHOSE ROUTING MONTHLY BILLS ARE GREATER THAN THEIR NET MONTHLY INCOME MAY BE ELIGIBLE FOR A REDUCED TIME PAYMENT AND WOULD MAKE MONTHLY PAYMENTS FOR (12 TO 18 MONTHS) TO PAY OFF THE AMOUNT WE DETERMINED THEY CAN AFFORD TO PAY. ONCE THE FAP APPLICATION IS FINALIZED AND A PATIENT IS DEEMED ELIGIBLE TO PAY NOTHING OR A REDUCED TIME PAYMENT THIS AGREEMENT IS FOR ONE YEAR AND ALSO INCLUDES PREVIOUS BALANCES THE PATIENT INCURRED. ALL PATIENTS ARE ADVISED OF MSKCC'S FINANCIAL ASSISTNACE PROGRAM AND THE DETERMINATION IS DOCUMENTED ONLY IF A PATIENT APPLIES. 20 LAURANCE S ROCKEFELLER OP PAVILION 160 EAST 53RD STREET NEW YORK NY 10022 EXTENSION CLINIC BREAST AND IMAGING CENTER 300 EAST 66TH STREET NEW YORK NY 10065 EXTENSION CLINIC MSKCC COMMACK 650 COMMACK ROAD COMMACK NY 11725 EXTENSION CLINIC MSKCC BASKING RIDGE-AMBULATORY CARE 136 MOUNTAIN VIEW BLVD BASKING RIDGE NJ 07920 EXTENSION CLINIC MSK WEST HARRISON 500 WESTCHESTER AVENUE WEST HARRISON NY 10604 EXTENSION CLINIC JOSIE ROBERTSON SURGERY CENTER 1133 YORK AVENUE NEW YORK NY 10065 EXTENSION CLINIC MSKCC - 64TH STREET 205 EAST 64TH STREET NEW YORK NY 10065 EXTENSION CLINIC SIDNEY KIMMEL CTR FOR PROSTATE & UROLOGI 353 EAST 68 STREET NEW YORK NY 10065 EXTENSION CLINIC MSKCC ROCKVILLE CENTER 1000 NORTH VILLAGE AVENUE ROCKVILLE CENTER NY 11570 EXTENSION CLINIC MSKCC 60TH STREET 16 EAST 60TH STREET NEW YORK NY 10022 EXTENSION CLINIC MSKCC BROOKLYN INFUSION CENTER 557 ATLANTIC AVENUE BROOKLYN NY 11217 EXTENSION CLINIC SILLERMAN CENTER FOR REHABILITATION 515 MADISON AVENUE NEW YORK NY 10022 EXTENSION CLINIC MSKCC HAUPPAUGE 800 VETERANS MEMORIAL HIGHWAY HAUPPAUGE NY 11787 EXTENSION CLINIC MSK MONMOUTH 480 RED HILL ROAD MIDDLE TOWN NJ 07748 EXTENSION CLINIC HARLEM BREAST EXAMINATION CENTER CLINIC 163 WEST 125TH STREET NEW YORK NY 10027 EXTENSION CLINIC MSK COUNSELING CENTER 641 LEXINGTON AVENUE NEW YORK NY 10022 EXTENSION CLINIC MSK IMAGING CENTER 301 EAST 55TH STREET NEW YORK NY 10022 EXTENSION CLINIC POST TREATMENT RESOURCES PROGRAM 215 EAST 68TH STREET NEW YORK NY 10065 EXTENSION CLINIC THE BENDHEIM INTEGRATIVE MEDICINE CENTER 1429 FIRST AVENUE NEW YORK NY 10021 EXTENSION CLINIC MSKCC SLEEPY HOLLOW - CLOSED 72016 777 NORTH BROADWAY SLEEPY HOLLOW NY 10591 EXTENSION CLINIC SCHEDULE H PART 1, LINE 3C A PATIENT WITH INCOME LESS THAN OR EQUAL TO 500% OF THE FEDERAL POVERTY GUIDELINES (FPG) IS ELIGIBLE FOR THE INSTITUTIONS FINANCIAL ASSISTANCE PROGRAM (FAP). THE INSTITUTION MAY REDUCE THE FEES INCURRED BY THE PATIENT OR ACCEPT AS FULL PAYMENT AMOUNTS PAID BY THE INSURANCE CARRIER ON THE PATIENTS BEHALF. IN ADDITION, A PATIENT MAY ALSO QUALIFY FOR ASSISTANCE EVEN IF HIS/HER INCOME IS GREATER THAN THE THRESHOLD LIMIT. THE INSTITUTION ADJUSTS PATIENTS INCOME FOR ROUTINE MONTHLY EXPENSES, INCLUDING TAXES, TO DETERMINE DISPOSABLE INCOME. MSKCC ALSO DEDUCTS A SPECIFIC AMOUNT (DEBT BURDEN) AS A MONTHLY CLOTHES AND FOOD ALLOWANCE BASED ON A PATIENTS FAMILY SIZE IN EVALUATING THE TYPE AND AMOUNT OF ASSISTANCE NEEDED. FAMILY ALLOWED RESOURCE SIZE INCOME LEVELS 1 $ 59,400 $33,096 2 $ 80,100 $40,734 3 $100,800 $48,372 4 $121,500 $56,012 5 $142,200 $63,856 6 $162,900 $71,288 PART I, LINE 7G MEMORIAL SLOAN KETTERING CANCER CENTER HAS CONSISTENTLY SET THE STANDARD OF CARE FOR PEOPLE WITH CANCER BY EMPHASIZING EARLY DETECTION, PRECISE DIAGNOSIS, AND INDIVIDUALLY TAILORED TREATMENT. THE HOSPITAL SUBSIDIZES CANCER SCREENING, TREATMENT, AND SUPPORT SERVICES TO FULFILL ITS MISSION AND TO HELP REDUCE CANCER HEALTH DISPARITIES AMONG MINORITY AND MEDICALLY UNDERSERVED POPULATIONS. MSKCCS BREAST EXAMINATION CENTER OF HARLEM (BECH) PROVIDES BREAST AND CERVICAL CANCER SCREENING, COUNSELING AND PATIENT FOLLOW-UP, AS WELL AS EDUCATIONAL PROGRAMS TO UNINSURED PATIENTS THROUGHOUT THE NEW YORK CITY AREA. BECH HAS A DEDICATED STAFF, INCLUDING A HEALTH EDUCATOR WHOSE ROLE IS TO INITIATE AND IMPLEMENT OUTREACH ACTIVITIES IN HARLEM AND THE SURROUNDING COMMUNITIES. SINCE ITS INCEPTION IN 1979, BECH HAS HAD MORE THAN 241,464 VISITS, WITH 2,207 OF THOSE VISITS TAKING PLACE IN 2016. ALL SERVICES WERE PROVIDED AT NO OUT-OF-POCKET EXPENSE TO THE WOMEN WHO RECEIVED CANCER SCREENING AND FOLLOW-UP SERVICES. LOCATED IN HARLEM, THE RALPH LAUREN CENTER FOR CANCER CARE AND PREVENTION (RLCCCP) OFFERS CANCER SCREENING AND TREATMENT SERVICES TO ITS MEDICALLY UNDERSERVED COMMUNITY. THE RLCCCP, MADE POSSIBLE IN PART THROUGH A GIFT FROM THE POLO RALPH LAUREN CORPORATION, IS SOLELY OWNED AND MANAGED BY MSKCC. SINCE ITS INCEPTION RLCCCP HAS CONDUCTED MORE THAN 128,765 VISITS, OF WHICH APPROXIMATELY 11,261 OCCURRED IN 2016. RLCCCP CONTINUES TO PROVIDE CARE TO INDIVIDUALS ON MEDICAID AND MEDICAID MANAGED CARE PROGRAMS. TO BETTER SERVE THE NEEDS OF DIAGNOSED PATIENTS, THE RALPH LAUREN CENTER HAS EXPANDED ITS NAVIGATION EFFORTS BY CREATING A MULTIDISCIPLINARY TEAM FOR EACH ONCOLOGIST, CONSISTING OF A CLINICAL NURSE NAVIGATOR AND LAY NAVIGATOR. BOTH NAVIGATORS ASSIST PATIENTS FROM THE TIME OF DIAGNOSIS TO COMPLETION OF TREATMENT AND BEYOND. THE CLINICAL NAVIGATOR FOCUSES ON MEDICAL ISSUES, WORKING WITH THE ONCOLOGIST TO ENSURE THAT PATIENTS UNDERSTAND THEIR DIAGNOSIS AND TREATMENT PLAN. THE LAY NAVIGATOR WORKS WITH THE PATIENTS TO ELIMINATE BARRIERS SUCH AS TRANSPORTATION AND LINKING PATIENTS TO SERVICES IN THE COMMUNITY AS DEEMED NECESSARY. MEMORIAL SLOAN KETTERING CANCER CENTERS PSYCHIATRY & BEHAVIORAL SERVICES DEPARTMENT OFFERS INPATIENT AND OUTPATIENT PSYCHOLOGICAL AND SOCIAL SUPPORT SERVICES TO PATIENTS, THEIR FAMILIES, AND CAREGIVERS. ALL MEDICAID OUTPATIENT VISITS AND INPATIENT ENCOUNTERS ARE SUBSIDIZED BY MEMORIAL SLOAN KETTERING CANCER CENTER, AS ARE UNREIMBURSED TIME AND EFFORT BY NURSES TO STAFF A SMOKING CESSATION CLINIC. APPROXIMATELY 1,762 PATIENTS AGREED TO PARTICIPATE IN TREATMENT BY THE NURSING STAFF DURING 2016. PHILANTHROPIC FUNDS ARE USED TO SUPPORT A SIGNIFICANT NUMBER OF THE DEPARTMENTS OVERALL CLINICAL AND TRAINING ACTIVITIES. THE TOTAL RELATED PERSONAL COST WAS $1.9M. THE INTEGRATIVE MEDICINE SERVICE PROVIDES FREE CLINICAL CARE FOR INPATIENTS AND OUTPATIENTS. DURING 2016, THE SERVICE PROVIDED 8,849 TREATMENTS WITH A RELATED PERSONAL COST OF $905,000. THE CLINICAL SERVICES PROVIDED INCLUDE MUSIC THERAPY, TOUCH THERAPY, ACUPUNCTURE, YOGA AND YOGIC BREATHING, MEDITATION, GUIDED IMAGERY, KARATE, AND DANCE THERAPY. A TOUCH THERAPY FOR CAREGIVERS COURSE IS OFFERED FREE OF CHARGE TO ANY INPATIENT AND THEIR FAMILY MEMBERS ONCE PER MONTH. PART I, LINE 7, COLUMN (F) THE AMOUNT OF THE BAD DEBT EXPENSE REMOVED FROM THE 2016 CALCULATION IS $25,874,966. PART I, LINE 7 FINANCIAL ASSISTANCE REPRESENTS THE COST OF SERVICES PROVIDED TO PATIENTS WHO CANNOT AFFORD HEALTH CARE SERVICES DUE TO INADEQUATE RESOURCES AND/OR ARE UNINSURED OR UNDERINSURED. A PATIENT IS CLASSIFIED AS A FINANCIAL ASSISTANCE PATIENT IN ACCORDANCE WITH THE INSTITUTIONS ESTABLISHED POLICIES AND WHERE INSUFFICIENT PAYMENT FOR SUCH SERVICES IS ANTICIPATED. THE INSTITUTION CONSIDERS PATIENTS FOR FINANCIAL ASSISTANCE IF HOUSEHOLD INCOME IS LESS THAN 500% OF THE FEDERAL POVERTY GUIDELINES. SERVICES PROVIDED AS FINANCIAL ASSISTANCE ARE NOT REPORTED AS REVENUE. THE COSTS REPORTED IN THE TABLE ON LINE 7,WERE BASED ON VARIOUS SOURCES. FINANCIAL ASSISTANCE AND UNREIMBURSED MEDICAID AND MEDICARE COMMUNITY BENEFITS COST WERE BASED ON A COST TO CHARGE RATIO CALCULATION. THE TOTAL CHARGES ASSOCIATED WITH THESE PROGRAMS ARE MULTIPLIED BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITALS NEW YORK STATE INSTITUTIONAL COST REPORT. THE COSTS ASSOCIATED WITH A PORTION OF THE HEALTH PROFESSIONAL EDUCATION COMMUNITY BENEFIT ARE OBTAINED FROM THE STEP-DOWN OF COSTS PREPARED AS PART OF THE MEDICARE COST REPORT. COST OF PROVIDING FINANCIAL ASSISTANCE AS CALCULATED PER THE ABOVE IS NET OF AMOUNTS RECEIVED FROM THE NEW YORK STATE BAD DEBT AND CHARITY CARE POOLS. TO ARRIVE AT THE AMOUNTS REPORTED IN THE TABLE ON LINE 7, ADDITIONAL STEPS AS OUTLINED BELOW WERE TAKEN. UNPAID COST OF GOVERNMENT SPONSORED HEALTH CARE REPRESENTS THE ESTIMATED DIFFERENCE BETWEEN THE PAYMENTS MADE UNDER THE MEDICARE AND MEDICAID PROGRAMS AND THE INSTITUTIONS COST OF PROVIDING THESE SERVICES AS CALCULATED ABOVE. THE INSTITUTION SUBTRACTS ALL REVENUES RECEIVED FROM THE MEDICARE AND MEDICAID PROGRAMS TO DETERMINE THE COMMUNITY BENEFIT PROVIDED. RESEARCH COMMUNITY BENEFIT COSTS REPRESENT ALL COSTS FOR BASIC TRANSLATIONAL AND CLINICAL RESEARCH, SUPPORTED BY INSTITUTIONAL FUNDS, GOVERNMENTAL, AND OTHER NON-PROFIT ORGANIZATIONS. RESEARCH COSTS SUPPORTED BY PHILANTHROPIC FUNDS, TOTALING $127.3M ARE NOT INCLUDED IN SCHEDULE H, PART I, LINE 7. THE INSTITUTION IS A PREEMINENT PROVIDER OF HEALTH TRAINING TO HEALTH PROFESSIONALS WHO DESIRE TRAINING IN THE SKILLS NECESSARY TO TREAT CANCER PATIENTS. THE INSTITUTION TRAINS PHYSICIANS, SCIENTISTS, MEDICAL STUDENTS, RADIOLOGY STUDENTS, NURSING STUDENTS, SOCIAL WORK STUDENTS AND INDIVIDUALS LOOKING TO CREATE A CAREER IN THE FIELD OF CANCER BIOLOGY. THE AMOUNTS REPORTED AS HEALTH TRAINING REPRESENT INSTITUTIONAL FUNDS, AS WELL AS COSTS IN EXCESS OF AMOUNTS REIMBURSED BY THIRD PARTY PAYERS SUCH AS TRAINING GRANT REVENUES AND DIRECT MEDICAL EDUCATION PAYMENTS FROM THE MEDICARE PROGRAM. PART II MSKCC ENGAGES IN AND SUPPORTS COALITION BUILDING ACTIVITIES THAT PROMOTE THE HEALTH OF THE COMMUNITIES THE INSTITUTION SERVES. STAFF MEMBERS ARE ENCOURAGED TO SHARE THEIR CLINICAL EXPERTISE AND EXPERIENCE WITH PARTNERING HEALTHCARE FACILITIES AND COMMUNITY ORGANIZATIONS. STAFF MEMBERS SERVE AND PARTICIPATE IN NUMEROUS COMMUNITY GROUPS INCLUDING THE AMERICAN CANCER SOCIETY, THE AMERICAN PUBLIC HEALTH ASSOCIATION, THE GREATER NEW YORK HOSPITAL ASSOCIATION, AND MANY HEALTH IMPROVEMENT ADVOCACY GROUPS FOR PARTICULAR TYPES OF CANCER. ALTHOUGH THE SIGNIFICANT COST OF STAFF TIME DEVOTED TO THESE ACTIVITIES IS NOT QUANTIFIED BY THE CENTER, THE INSTITUTION CONSIDERS THESE EFFORTS TO COLLABORATE AND BUILD COMMUNITY RESOURCES TO BE OF SIZEABLE COMMUNITY BENEFIT. PART III, LINE 2 THE AMOUNT ON LINE 2 IS THE ACTUAL 2016 BAD DEBT WRITE-OFF WHICH IS DERIVED BY TAKING THE GROSS CHARGES ASSOCIATED WITH THE PROVISIONS FOR BAD DEBTS AND MULTIPLYING BY A RATIO OF HISTORICAL EXPENSES TO CHARGES AS DERIVED FROM THE HOSPITALS NEW YORK STATE INSTITUTIONAL COST REPORT. A SEPARATE RATIO IS CALCULATED FOR EACH TYPE OF PATIENT CARE ACTIVITY: INPATIENT, OUTPATIENT AND PHYSICIAN. PART III, LINE 3 PATIENTS HAVE THE OPPORTUNITY TO PURSUE VARIOUS FINANCIAL ASSISTANCE PROGRAMS THROUGH MSKCCS FINANCIAL ASSISTANCE PROGRAM. IF A PATIENT IS FOUND TO HAVE THE APPROPRIATE RESOURCES TO PAY FOR HEALTH SERVICES AND DOES NOT, OR CHOOSES NOT TO PARTICIPATE IN AVAILABLE HEALTH BENEFIT PROGRAMS THE COLLECTION PROCESS WILL BE PURSUED IN ACCORDANCE WITH THE INSTITUTIONS POLICY. ONCE DEEMED UNCOLLECTABLE, THE CHARGES ARE CLASSIFIED AS BAD DEBTS AND ARE CHARGED OFF AS SUCH. THE AMOUNTS IN THE TABLE, ON LINE 7, REFLECTS THE COST OF THESE ACCOUNTS AS CALCULATED BASED ON THE COST-TO-CHARGE RATIO METHODOLOGY DESCRIBED EARLIER WHERE APPLICABLE. IN DETERMINING THE AMOUNT THAT REASONABLY COULD BE ATTRIBUTABLE TO PATIENTS WHO LIKELY WOULD QUALIFY FOR FINANCIAL ASSISTANCE UNDER THE INSTITUTIONS POLICY, THE INSTITUTION REVIEWED THE CASES THAT WERE CLOSED WITH AN "INCO PART VI, LINE 7 NEW YORK STATE DISCLOSURE IN ACCORDANCE WITH REVENUE PROCEDURE 2015-21: IN ACCORDANCE WITH REVENUE PROCEDURE 2015-21, MSKCC IS DISCLOSING THE FOLLOWING INFORMATION WITH RESPECT TO SECTION 501(R) ISSUES THAT WERE DISCOVERED DURING THE 2016 TAX YEAR AND HOW THEY HAVE BEEN CORRECTED, TO SATISFY SECTION 501(R)(1) AND 501(R)(2)(B) REQUIREMENTS. FOR ALL ITEMS: THE CAUSE WAS A GOOD-FAITH EFFORT TO IMPLEMENT THE REQUIREMENTS OF THE SECTION 501(R) REGULATIONS. MSKCC OBTAINED INFORMATION ABOUT THE REQUIREMENTS AND IMPLEMENTED THEM, THOUGH THERE WERE SOME GAPS DUE TO THE DETAILED NATURE OF THE REGULATIONS. THE ISSUES WERE DISCOVERED DURING FEBRUARY 2016 WHEN MSKCC REVIEWED ITS 2016 FACILITY POLICIES AND PRACTICES AS PART OF ITS PROCEDURES DESIGNED TO MONITOR AND ACHIEVE OVERALL COMPLIANCE WITH THE SECTION 501(R) REGULATIONS. THE CORRECTIONS WERE COMPLETED DIRECTLY AFTERWARDS (ALL WERE COMPLETED WITHIN TAX YEAR 2016). MSKCC HAS NOT IDENTIFIED ANY PERSONS DIRECTLY AFFECTED BY THESE ISSUES BECAUSE THE DISCREPANCIES RELATED PRIMARILY TO THE SPECIFICITY OF INFORMATION CONTAINED IN DOCUMENTS; THE PRACTICES WERE ACTIVELY BEING FOLLOWED. ALL INDIVIDUALS WOULD HAVE BEEN IN THE SAME POSITION. TO ENSURE FULL COMPLIANCE WITH SECTION 501R REGULATIONS, MSKCC HAS ENGAGED AN OUTSIDE CONSULTANT TO REVIEW ITS POLICIES AND PRACTICES IN A TIMELY FASHION AND TO PROVIDE FEEDBACK AS NECESSARY. SPECIFIC ISSUES AND CORRECTIONS: PART V #13 - 16 1. REQUIREMENT: INCLUSION OF A PROVIDER LIST A HOSPITAL FACILITYS FINANCIAL ASSISTANCE POLICY (FAP) IS REQUIRED TO LIST THE PROVIDERS, OTHER THAN THE HOSPITAL FACILITY ITSELF, DELIVERING EMERGENCY OR OTHER MEDICALLY NECESSARY CARE IN THE HOSPITAL FACILITY AND TO SPECIFY WHICH PROVIDERS ARE COVERED BY THE HOSPITAL FACILITYS FAP (AND WHICH ARE NOT). CONDITION: ALL OF MSKCCS PROVIDERS AND SITES ARE COVERED UNDER MSKCCS FAP. AS SUCH, IF A PATIENT IS CONSIDERED ELIGIBLE FOR MSKCCS FAP PROGRAM HE/SHE IS AUTOMATICALLY COVERED FOR ALL PATIENT COST RESULTING FROM HOSPITAL AND PHYSICIAN CHARGES. CONSEQUENTLY, MSKCC DID NOT ORIGINALLY JUDGE IT NECESSARY TO PUBLISH A PROVIDERS LIST. CORRECTIVE ACTION: MSKCC REVISED ITS FAP TO INCLUDE THE FOLLOWING TEXT, WHICH MAKES CLEAR THAT THERE ARE NO PROVIDERS OTHER THAN MSKCC ITSELF THAT PROVIDE MEDICALLY NECESSARY CARE BECAUSE ALL ARE EMPLOYEES OF MSKCC: ALL HOSPITAL PHYSICIANS ARE MSKCCS EMPLOYEES AND ALL SERVICES THEY PROVIDE ARE COVERED UNDER OUR FAP REPRESENTING HOSPITAL AND PHYSICIAN CHARGES INCURRED AT ALL OF OUR FACILITIES IRRESPECTIVE OF THE ATTENDING PHYSICIAN. TO APPLY FOR FAP, PLEASE VISIT OUR WEBSITE AT, WWW.MSKCC.ORG/FINANCE-ASSISTANCE; CALL OUR DEDICATED FAP LINE AT 212-639-3810 OR GO TO OUR PATIENT FINANCIAL SERVICES OFFICE AT 1275 YORK AVENUE, NEW YORK, NY 10065, ROOM C130 ON THE 1ST FLOOR. MSKCC FURTHER REVISED ITS PLAIN LANGUAGE SUMMARY TO INCLUDE: IF YOU RECEIVE SERVICES BY A NON-MSKCC PHYSICIAN CONSULTANT AT ANY OF OUR MSKCC LOCATIONS YOU WILL NOT RECEIVE A SEPARATE BILL AND THESE CHARGES WILL ALSO BE COVERED UNDER THE FAP. JUSTIFICATION: THE HOSPITAL HAS OVER 900 PHYSICIANS ON STAFF WHO ATTEND TO PATIENTS, THEREBY GENERATING BILLING ACTIVITIES. SOME OF THESE PHYSICIANS MAY CHANGE THROUGHOUT THE YEAR. ALTHOUGH OCCASIONALLY (NO MORE THAN TWICE A YEAR), THE HOSPITAL MAY REQUEST THE SERVICES OF A NON-EMPLOYEE CONSULTANT TO ADDRESS A SPECIFIC PATIENTS NEED; LISTING ALL OF MSKCC'S PHYSICIANS WOULD ONLY SERVE TO CONFUSE THE PATIENTS. PART V #17 2. REQUIREMENT:DESCRIPTION OF BILLING & COLLECTION PRACTICES A HOSPITALS FAP (OR SEPARATE BILLING AND COLLECTION POLICY) MUST INCLUDE INFORMATION ON THE ACTIONS A HOSPITAL WILL TAKE TO COLLECT OUTSTANDING BALANCES, INCLUDING THE REASONABLE EFFORTS MADE TO DETERMINE FAP-ELIGIBILITY. CONDITION: THE FAP ADEQUATELY REFERENCED THE BILLING AND COLLECTION POLICY AND THE FAP WAS WIDELY PUBLICIZED ON THE HOSPITALS WEBSITE, PLACED IN VARIOUS OFFICES AND MAILED OUT ETC, HOWEVER, THEY DID NOT FULLY DETAIL ALL OF THE REASONABLE EFFORTS THAT MSKCC IS REQUIRED TO MAKE, PER THE REQUIREMENT. CORRECTIVE ACTION: THE FOLLOWING TEXT WAS INCLUDED IN THE FAP BROCHURE: IF YOU ARE DEEMED ELIGIBLE TO MAKE A PAYMENT EACH MONTH AND YOU MISS A PAYMENT YOU WILL BE CONSIDERED TO HAVE DEFAULTED ON YOUR PAYMENT OBLIGATION, WHICH MAY RESULT IN YOUR ACCOUNT BEING SENT TO COLLECTIONS WITHIN 60 DAYS. IF YOU WOULD LIKE A COPY OF MEMORIAL HOSPITALS BILLING AND COLLECTIONS POLICY, PLEASE CALL PATIENT BILLING SERVICES AT (IN-STATE) 646-227-3378 OR (OUT-OF-STATE) 866-248-1274 OR GO TO OUR WEBSITE: WWW.MSKCC.ORG/FINANCIAL-ASSISTANCE MSKCC ALSO CREATED AN INDIVIDUAL BILLING AND COLLECTION POLICY IN 2016 AND POSTED IT ONTO THE FAP WEBSITE IN 2017. PART V #16C 3. REQUIREMENT: PLAIN LANGUAGE SUMMARY OF THE FAP A HOSPITAL MUST HAVE A PLAIN LANGUAGE SUMMARY OF THE FAP THAT INCLUDES REQUIRED INFORMATION AND MUST BE TRANSLATED INTO THE SAME LANGUAGES AS THE FAP AND FAP APPLICATION. CONDITION: THE HOSPITALS PLAIN LANGUAGE SUMMARY MET MOST OF THE REQUIREMENTS OF THE REGULATION; BUT IT DID NOT FULLY DESCRIBE ASSET LIMITATIONS ON FAP ELIGIBILITY AND INCLUDE A STATEMENT THAT A FAP ELIGIBLE INDIVIDUAL MAY NOT BE CHARGED MORE THAN AMOUNTS GENERALLY BILLED (AGB) FOR EMERGENCY OR OTHER MEDICALLY NECESSARY CARE. CORRECTIVE ACTION: MSKCC UPDATED THE PLAIN LANGUAGE SUMMARY TO INCORPORATE PATIENTS ASSET AND RESOURCES LEVELS AND INCLUDE A STATEMENT THAT A FAP ELIGIBLE INDIVIDUAL MAY NOT BE CHARGED MORE THAN AGB FOR EMERGENCY OR OTHER MEDICALLY NECESSARY CARE. THE SUMMARY IS POSTED TO THE FAP WEBSITE WITH TRANSLATIONS IN ENGLISH, SPANISH, CHINESE AND RUSSIAN. PART V #14 4. REQUIREMENT: CALCULATION OF AMOUNTS GENERALLY BILLED A HOSPITAL FACILITYS FAP MUST INCLUDE THE METHOD THE HOSPITAL FACILITY USES TO DETERMINE THE AMOUNTS GENERALLY BILLED TO INDIVIDUALS WHO HAVE INSURANCE COVERING EMERGENCY OR OTHER MEDICALLY NECESSARY CARE (AGB) AND MUST DESCRIBE THIS IN THE FAP. CONDITION: THE FAP DID NOT ADEQUATELY EXPLAIN THE METHOD USED TO DETERMINE AGB PER THE REQUIREMENT. CORRECTIVE ACTION: MSKCC ADDED TO ITS FAP WEBSITE A SUMMARY DOCUMENT EXPLAINING THE CALCULATION OF THE AMOUNTS GENERALLY BILLED IN ENGLISH, SPANISH, CHINESE AND RUSSIAN. THIS "LOOK BACK METHOD" EXPLAINS THAT AN INDIVIDUAL WHO IS DETERMINED TO BE ELIGIBLE FOR FAP WILL NEVER BE CHARGED MORE FOR MEDICALLY NECESSARY CARE THAN 45 PERCENT OF TOTAL HOSPITAL CHARGES (BOTH INPATIENT AND OUTPATIENT) WHICH IS THE AVERAGE AMOUNT MSKCC ARE REIMBURSED FROM MEDICARE FEE FOR SERVICE AND MSKCCS PRIVATE PAYERS. A SEPARATE AGB IS CALCULATED FOR THE PHYSICIAN CLAIMS USING THE SAME METHODOLOGY BUT THE CALCULATED PERCENTAGE IS 44%. PART V #1A, C & D ADDITIONAL DISCLOSURE REGARDING MINOR OMISSIONS FROM COMMUNITY HEALTH NEEDS ASSESSMENT (CHNA) REPORT: MSKCC REVIEWED THE CONTENT OF ITS MOST RECENT CHNA REPORT AND IMPLEMENTATION STRATEGY AS PART OF THE SAME PROCEDURES DESIGNED TO ACHIEVE OVERALL COMPLIANCE WITH 501(R). WHILE MSKCC BELIEVES THAT THE ITEMS IDENTIFIED ARE MINOR AND WERE EITHER INADVERTENT OR DUE TO REASONABLE CAUSE, IT HAS REVISED ITS CHNA AND IMPLEMENTATION STRATEGY, POSTED UPDATED VERSIONS TO ITS WEBSITE, AND IS DISCLOSING INFORMATION HERE IN THE INTEREST OF TRANSPARENCY. THE MINOR OMISSIONS AND THEIR CORRECTIONS INCLUDED:ADDING CITATIONS TO DATA SOURCE IN CERTAIN AREAS, CLARIFYING THE RELATIONSHIP BETWEEN "COMMUNITY"PRIMARY COUNTIES SERVED", ADDING INFORMATION ABOUT COMMUNITY RESOURCES AND ORGANIZATIONS SOLICITED FOR INPUT, SPECIFYING AND EVALUATING ACTIONS TAKEN SINCE THE PRIOR CHNA, AND CLARIFYING IN THE IMPLEMENTATION STRATEGY WHICH NEEDS ARE BEING ADDRESSED AND HOW THEY ARE GROUPED TOGETHER. true RALPH LAUREN CENTER FOR CANCER & PREVENTION 1919 MADISON AVENUE New York NY 10035 020597827 501(C)(3) 1100000 OPERATING LOSSES 1 STIPENDS 411 23938386 Form 990, Schedule I FOR THE YEAR 2016, THE AMOUNT IS FOR STIPENDS PAID TO 344 RESEARCH FELLOWS AND 67 GRADUATE SCHOOL STUDENTS. EDUCATION AND TRAINING INCLUDES CLASSROOM INSTRUCTION WITH HANDS-ON EXPERIENCE IN BOTH RESEARCH LABORATORIES AND CLINICAL CARE ACTIVITIES. THE AFOREMENTIONED GRANTEES ARE REQUIRED TO BE IN COMPLIANCE WITH ACADEMIC REQUIREMENTS. THIS INCLUDES DIRECT SUPERVISION AND DIRECTION BY PHYSICIANS AND RESEARCH INVESTIGATORS. RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION (RLC) DURING 2016 MSKCC PAID $1,100,000 TO THE RALPH LAUREN CENTER FOR CANCER CARE & PREVENTION TO OFFSET OPERATING EXPENSES. THE AMOUNT PAID IN THE CURRENT YEAR INCLUDES $100,000 FOR 2015 LOSSES. THE BOARD HAD APPROVED RESOLUTIONS TO SUPPORT THE RALPH LAUREN CENTER'S LOSSES UP TO $1,000,000 PER YEAR FROM 2014 - 2016. MSKCC REGULARLY MEETS WITH THE RALPH LAUREN CENTER'S BOARD OF DIRECTORS TO DETERMINE WHETHER THEIR SPENDING IS IN CONFORMITY WITH THE RALPH LAUREN CENTER'S MISSION. X X true true X X X X false true false false false false false true true true JOHN R GUNN 2015 FORMER COO 229167 229167 MICHAEL P GUTNICK EXECUTIVE VP & CFO 911697 689772 47519 39700 33006 1721694 18500 MARK SVENNINGSON SVP FINANCE & CONTROLLER 600143 245786 33656 39700 41670 960955 18500 ERIC M COTTINGTON PHD SVP RESEARCH & TECHNOLOGY MGMT 538639 289266 57118 39700 37296 962019 18500 THOMAS KELLY MD FORMER DIRECTOR S.K.I 520039 36743 39700 35013 631495 18500 JASON KLEIN SVP-CHIEF INVESTMENT OFFICER 834561 1949306 27555 1552528 40315 4404265 18500 EDWARD MAHONEY SVP FACILITIES MGMT & CONST 516489 1011733 33071 39700 28333 1629326 17624 KENNETH MARIANS PHD DEAN, GERSTNER GRADUATE SCHOOL 525819 30159 39700 37379 633057 18500 KATHRYN MARTIN CHIEF OPERATING OFFICER 1000437 707700 30119 39700 41613 1819569 18500 RICHARD K NAUM SVP DEVELOPMENT 425903 218495 38754 38399 39136 760687 17198 ROGER PARKER ESQ EVP & GENERAL COUNSEL 292325 325780 24827 24056 5499 672487 18500 PATRICIA C SKARULIS SVP-CHIEF INFORMATION OFFICER 625211 315173 18500 39700 15105 1013689 18500 ANNE MCSWEENEY SPECIAL ADVISOR TO PRESIDENT 967518 279362 60855 30450 41730 1379915 9250 SIMON N POWELL MD CHAIR & ATTEND RAD ONCOLOGY 1330549 236792 149227 30450 33092 1780110 9250 PETER T SCARDINO MD CHAIRMAN & ATTENDING SURGERY 1637498 1000000 57521 30450 65052 2790521 9250 PHILIP GUTIN MD CHAIR & ATTENDING NEUROSURGERY 2737738 9250 28338 25928 2801254 9250 JOSEPH DISA MD ATTENDING PLASTIC SURGERY 1538536 67862 30450 43839 1680687 9250 CRAIG B THOMPSON MD PRESIDENT & CEO 1558276 3740063 39032 1213562 168270 6719203 18500 CAROLYN B LEVINE ESQ DEPUTY GEN COUNSEL CORP SECTY 367785 111395 7391 25849 12669 525089 4775 JOSE BASELGA MD PHD PIC & CHIEF MEDICAL OFFICER 988284 489851 86808 39700 42573 1647216 18500 KERRY BESSEY SVP & CHIEF HR OFFICER 550375 279377 66688 39700 29104 965244 18500 MARK BILSKY MD ATTENDING-DEPT OF NEUROSURGERY 1691890 14632 330450 35962 2072934 9250 AVICE MEEHAN SVP CH COMMUNICATION OFFICER 393441 201250 11263 25698 29208 660860 6875 EDWIN TALIAFERRO VP INTERNAL AUDIT & COMPLIANCE 306469 159150 46507 26530 23706 562362 5330 RICHARD BARAKAT MD DPIC-REGIONAL CARE NETWORK 996017 151960 24098 30450 45558 1248083 9250 PAUL SABBATINI MD DPIC CLINICAL RESEARCH 563595 165000 21799 30450 25435 806279 9250 ELIZABETH MCCORMICK MSNRN SVP & CH NURSING OFFICER 470221 143222 18500 38360 16530 686833 18500 CYNTHIA MCCOLLUM SVP HOSPITAL OPERATIONS 465074 119351 18500 39700 25085 667710 18500 MARGARET BURKE SVP AMBULATORY CARE-HOSP OPS 466225 119351 84481 39700 37346 747103 18500 JOAN MASSAGUE PHD DIRECTOR, SLOAN KETTERING INST 811518 371350 138328 30450 21936 1373582 9250 FREDRICK GROVES EVP & HOSPITAL ADMINISTRATOR 549568 27495 28212 1689 606964 EPHRAIM CASPER MD MEDICAL DIRECTOR-REGIONALS 861342 7579 60853 26401 956175 0 ELIZABETH HERBERT SVP, HOSPITAL ADMINISTRATION 450549 119351 16424 39700 33430 659454 13091 JORGE LOPEZ EVP GENERAL COUNSEL 518293 27054 27537 19699 592583 BABAK MEHRARA MD Chief Attending-Surgery 1575197 12445 30450 36851 1654943 9250 Supplemental Compensation Information SCHEDULE J, PART I, LINE 1A BUSINESS OR FIRST CLASS TRAVEL IS ALLOWED FOR FLIGHTS GREATER THAN SIX CONTINUOUS HOURS FOR ANY EMPLOYEE NOT FUNDED BY FEDERAL GRANTS. EXCEPTIONS TO THE SIX HOUR RULE ARE REVIEWED ON AN INDIVIDUAL BASIS. ALL TRAVEL MUST BE APPROVED BEFORE ANY ARRANGEMENTS ARE MADE. MSKCC HAS AN ACCOUNTABLE TRAVEL POLICY AND THEREFORE, DOES NOT INCLUDE TRAVEL AS TAXABLE COMPENSATION. SCHEDULE J, PART II GRANDFATHERED MSKCC DEFERRED COMPENSATION PLANS Included in Other Reportable Compensation are certain distributions from deferred compensation plans that the Institution maintains for certain management and HIGHLY COMPENSATED employees. These grandfathered plans were adopted in the early and mid-1980s and have been closed to new participants since August 16, 1986. The grandfathered plans allowed participants to irrevocably defer portions of their approved salary until certain conditions were met, typically retirement or disability. In addition, the Institution made contributions to the plans to the extent contributions to the MSKCC Retirement Plan for such participants were limited by applicable contribution limits under the Internal Revenue Code. The Institution provided participants with the opportunity to receive distributions as permitted under Section 409A of the Internal Revenue Code. This opportunity was exercised by numerous participants. These distributed amounts are reported as W-2 compensation. 100 percent of these amounts reflect the deferral of a portion of the participant's approved compensation package and related investment experience since the commencement of an individual's plan participation. As contributions were made to these plans for previous periods, the contribution amounts were reported on Form 990 for the applicable period as contributions to deferred compensation plans with respect to officers, key employees, and other highest paid employees. These amounts, as adjusted for investment experience, are reported again now on Form 990 as distributions from the plans. THE DUTIES TO BE PERFORMED BY OUR PRESIDENT REQUIRE HIM TO BE ON CALL AND TO PERFORM DUTIES AS AND WHEN APPROPRIATE DURING HIS OFF-DUTY PERIODS AS WELL AS DURING NORMAL OFFICE HOURS. AN EMPLOYMENT CONTRACT REQUIRES OUR PRESIDENT TO LIVE IN THE OFFICIAL RESIDENCE OWNED AND MAINTAINED BY THE INSTITUTION. THE CONTRACT REQUIRES OUR PRESIDENT TO USE THE RESIDENCE FOR INSTITUTIONAL PURPOSES, INCLUDING, BUT NOT LIMITED TO, MEETINGS WITH AND ENTERTAINMENT OF STAFF, DONORS AND POTENTIAL DONORS, VISITING PROFESSORS AND SCIENTISTS, AND OTHER PERSONS INVOLVED WITH THE AFFAIRS OF THE INSTITUTION, CONFIDENTIAL INTERVIEWS WITH MEMBERS AND PROSPECTIVE MEMBERS OF THE STAFF; AND FOR OTHER INSTITUTIONAL ACTIVITIES CONDUCTED DURING AND OUTSIDE OF NORMAL OFFICE HOURS. THE COST IS REPORTED AS COMPENSATION ON FORM 990 AND IS EXCLUDED FROM TAXABLE COMPENSATION IN ACCORDANCE WITH CODE SECTION 119. SCHEDULE J, PART I LINE 4B - THE INSTITUTION MAINTAINS A NONQUALIFIED DEFERRED COMPENSATION PLAN WHICH IS USED FOR EMPLOYER CONTRIBUTIONS IN EXCESS OF THOSE ALLOWED BY THE RETIREMENT PLAN. LINE 7 - INCENTIVE PAY IS PROVIDED TO OFFICERS AND KEY EMPLOYEES BASED ON THEIR ACHIEVEMENT OF GOALS RELATING TO QUALITY OF CARE, PATIENT SAFETY, OPERATIONAL EFFICIENCY AND FINANCIAL PERFORMANCE. LINE 8 - AN EMPLOYMENT CONTRACT WAS ENTERED INTO AND SIGNED PRIOR TO EMPLOYMENT A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649903B91 2008-05-13 456109226 SEE PART VI false false false B DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 649906RK2 2012-02-16 388814944 SEE PART VI false false false C DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 6499063Z7 2013-06-28 80000000 SEE PART VI false false false D DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2015-07-16 100000000 SEE PART VI false false false A 75135000 0 456110736 0 0 0 2928705 0 0 0 453182031 0 2008 true false true true B 5280000 0 389043483 0 9172031 0 2651698 0 0 92720595 284499159 0 2014 false true true true C 26000000 0 80000000 0 0 0 0 0 0 0 80000000 0 2013 true false true true D 5308784 0 100300239 0 0 0 0 0 0 0 100300239 0 2015 false true true true A 0 B false false false true false 0 false false false true C false false false true false 0.00000 0.00000 0.00000 false false false true D false false false true false 0.00000 0.00000 0.00000 false false false true A false false false true false false 0 false 0 false true B false true false false false false 0 false 0 false true C false true false false false false 0 false 0 false true D false true false false false false 0 false 0 false true A true B true C true D true PART I, COLUMN (F) DESCRIPTION OF PURPOSE 2008-I & II CUSIP #649903ZR5 & #649903B91: 2008-I SERIES BONDS CUSIP #649903ZR5 WITH ISSUE PRICE $164,779,275 AND 2008-II SERIES BONDS CUSIP #649903B91 WITH ISSUE PRICE $291,329,951 ARE COMBINED FOR REPORTING PURPOSE UNDER CUSIP #649903B91. BOTH ISSUES WERE USED TO CURRENT REFUND A PORTION OF THE 2002A BONDS ISSUED JANUARY 24, 2002. 2012 & 2012-I SERIES CUSIP #649906RK2: 2012 SERIES BONDS WERE USED TO CONSTRUCT AND EQUIP AN AMBULATORY FACILITY A DORMITORY AUTHORITY OF THE STATE OF NEW YORK 146000293 000000000 2016-04-28 110000000 SEE PART VI false false false B NEW JERSEY ECONOMIC DEVELOPMENT AUTHORITY 222045817 000000000 2016-09-09 145000000 SEE PART VI false false false A 572866 0 110247909 0 0 0 155282 0 0 110017627 75000 0 2016 false false false true B 0 0 145000000 0 0 0 72861 0 0 144627139 300000 0 false false false true A false false false true false 0.00000 0.00000 0.00000 false false false true B false false false true false 0.00000 0.00000 0.00000 false false false true A false true false false false false 0 false 0 false true B false true false false false false 0 false 0 false true A true B true SIMON POWELL MD EMPLOYEE MORTGAGE X 1000000 600000 false true true RICHARD BARAKAT MD EMPLOYEE MORGTAGE X 500000 500000 false true true 1100000 MS T LINDSTEN SEE PART V 203712 FAMILY EMPLOYMENT false MR I GUTNICK SEE PART V 102944 FAMILY EMPLOYMENT false KING STREET CAPITAL MANAGEMENT SEE PART V 684233 INVESTMENT MANAGEMENT FEES false MR L SELBY SEE PART V 34489 FAMILY EMPLOYMENT false JOSE BASELGA MD PHD SEE PART V 74024 MMPC false BUSINESS TRANSACTIONS INVOLVING INTERESTED PERSONS 1. DR. THOMPSON IS THE PRESIDENT OF THE INSTITUTE. HIS SPOUSE IS A LABORATORY MEMBER FOR SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH. HER COMPENSATION FOR 2016 WAS $203,712. 2. MR. MICHAEL P. GUTNICK IS THE EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER. HIS SON IS A FUND COORDINATOR IN THE DIVISION OF MEDICINE IN THE HOSPITAL. HIS SON'S TOTAL COMPENSATION FOR 2016 WAS $102,944. 3. MS. JAMIE NICHOLLS IS A BOARD MEMBER OF THE INSTITUTION. HER SPOUSE IS A CO-FOUNDER OF KING STREET CAPITAL MANAGEMENT. DURING 2016, THE CENTER PAID KING STREET $684,233 IN MANAGEMENT FEES. THE INVESTMENT AGREEMENT CALLS FOR CARRIED INTEREST INCOME THAT IS NORMAL AND CUSTOMARY IN THE COURSE OF INVESTING IN ALTERNATIVE INVESTMENTS. NO CARRIED INTEREST INCOME WAS EARNED IN 2016. 4. MR. NORMAN C. SELBY IS A BOARD MEMBER WITHIN THE ORGANIZATION. HIS SON IS A RESEARCH FELLOW IN THE DEPARTMENT OF SURGERY IN THE HOSPITAL. HIS SON'S TOTAL COMPENSATION FOR 2016 WAS $34,489. 5. JOSE BASELGA MD PHD IS THE PHYSICIAN IN CHIEF AND CHIEF MEDICAL OFFICER OF THE ORGANIZATION. HE IS ALSO 100% OWNER OF MEMORIAL MEDICAL CARE PC. MEMORIAL MEDICAL CARE PC WAS ESTABLISHED TO PROVIDE HOME HEALTHCARE TO THE HOSPITAL'S BONE MARROW TRANSPLANT PATIENTS. THE PC AND THE HOSPITAL HAVE A MANAGEMENT AGREEMENT WHERE THERE IS NO COST TO THE HOSPITAL FOR THE SERVICE. THE HOSPITAL PROVIDES AND CHARGES THE PC FOR LEASED EMPLOYEES AND MEDICAL SERVICES AS NEEDED. PATIENTS ENROLLED IN THIS PROGRAM ARE BILLED ACCORDINGLY. THE AMOUNT REPORTED IS THE COST OF SUCH SERVICES PROVIDED TO THE PC. THE INDIVIDUALS LISTED WERE NOT A PARTY TO THE TRANSACTIONS. THERE IS NO SHARING OF THE INSTITUTION'S REVENUE. THE PURCHASES OF GOODS OR SERVICES BY THE INSTITUTION WERE MADE IN THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS, AT COMMERCIALLY AVAILABLE RATES NORMALLY CHARGED TO REGULAR CUSTOMERS. X 926390 THRIFT VALUE X 293 6265095 MARKET VALUE false true false PART I EXCLUDED FROM THIS VALUE ARE PLEDGE PAYMENTS, MADE BY STOCK, TOTALING $14,753,419. PROMISES TO GIVE ARE REPORTED AT THE DATE THE INTENT IS MADE IN WRITING. CLOTHING AND HOUSEHOLD GOODS ARE DONATED TO OUR THRIFT SHOP. THE SOCIETY OF MSKCC RUNS THE THRIFT SHOP FOR THE BENEFIT OF THE ORGANIZATION. PUBLICLY TRADED DONATED STOCK IS SOLD BY MERRILL LYNCH ON BEHALF OF MEMORIAL SLOAN-KETTERING CANCER CENTER AND ITS AFFILIATED ORGANIZATIONS. PART VI, LINES 6-7 THE ARTICLES OF INCORPORATION AND BY-LAWS WERE REVIEWED TO DETERMINE THAT THE SUPPORTED ORGANIZATIONS OUTLINED IN SCHEDULE-A HAVE THE POWER TO ELECT OR APPOINT MEMBERS TO THE BOARD OF THE SUPPORTING ORGANIZATIONS. ADDITIONALLY MEMORIAL SLOAN-KETTERING CANCER CENTER EIN 13-1924236, MSK, IS THE SINGLE MEMBER OF THE PROSTATE CANCER CLINICAL TRIALS CONSORTIUM LLC, PCCTC, WHO HAS ELECTED TO BE TREATED AS A DISREGARDED ENTITY OF MSK FOR TAX PURPOSES. MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES EIN 13-1624082 IS THE SINGLE MEMBER OF MSKCC PROPERTIES LLC, WHO HAS ELECTED TO BE TREATED AS A CORPORATION FOR TAX PURPOSES. PART VI, LINE 11B PRIOR TO FILING THE RETURN, A REVIEW OF THE 990 WAS CONDUCTED BY THE CONTROLLER AND THE CHIEF FINANCIAL OFFICER. IT IS THEN REVIEWED BY THE JOINT AUDIT COMMITTEE OF THE BOARD. THE JOINT AUDIT COMMITTEE REFERS THE FORM 990 TO THE FULL BOARD, AND A COPY IS PROVIDED TO EACH BOARD MEMBER FOR FURTHER REVIEW. MEMORIAL SLOAN-KETTERING'S FORM 990 IS REVIEWED BY OUTSIDE COUNSEL AND IS PREPARED IN CONJUNCTION WITH ERNST AND YOUNG, LLP. PART VI, LINE 12C THE COMPLIANCE OFFICER AND STAFF ARE RESPONSIBLE FOR ADMINISTERING THE CONFLICT OF INTEREST PROGRAM--INCLUDING THE IMPLEMENTATION OF THE POLICY--BY MAINTAINING PROCESSES FOR DISCLOSURE OF OUTSIDE ACTIVITIES AND FOR THE TIMELY REVIEW OF REPORTED INTERESTS, INCLUDING: 1. MANAGEMENT OF THE ANNUAL DISCLOSURE CERTIFICATION PROCESS AND THE PROCESS BY WHICH COVERED PERSONS DISCLOSE AT TIME OF HIRE. COVERED PERSONS RECEIVE AN ANNUAL QUESTIONNAIRE REQUESTING DISCLOSURE OF RELATIONSHIPS AND TRANSACTIONS THAT MIGHT INVOLVE A CONFLICT OF INTEREST. QUESTIONNAIRE RESPONSES ARE REVIEWED BY THE COMPLIANCE OFFICER AND STAFF. FOLLOW-UP INQUIRIES ARE MADE IF NEEDED. MATTERS ARE SUBMITTED TO AN INTERNAL MANAGEMENT COMMITTEE AND A COMMITTEE OF THE BOARD OF MANAGERS IF ADJUDICATION IS NEEDED. 2. REVIEW AND ADJUDICATION OF OUTSIDE ACTIVITIES THAT REQUIRE PRE- APPROVAL OR DISCLOSURE; FACILITATION OF A REVIEW BY THE OFFICE OF INDUSTRIAL AFFAIRS OF ANY OUTSIDE ACTIVITIES THAT INVOLVE INTELLECTUAL PROPERTY OR OTHERWISE INVOLVE AN ACTIVITY IN WHICH THE CENTER'S RIGHTS MAY REQUIRE PROTECTION. 3. ADMINISTRATION OF CONFLICT OF INTEREST ADVISORY COMMITTEE MEETINGS, INCLUDING DEVELOPMENT AND DISTRIBUTION OF AGENDAS AND SUPPORTING DOCUMENTS, DRAFTING AND DISTRIBUTION OF MINUTES, AND MAINTENANCE OF COMMITTEE RECORDS. 4.DOCUMENTATION OF THE OUTCOME OF ALL REVIEWS OF REPORTED OUTSIDE ACTIVITIES. COMMUNICATION TO THE COVERED PERSON OF THE OUTCOME OF ALL REVIEWS, INCLUDING DOCUMENTATION OF MANAGEMENT PLANS. AS PART OF THE CLINICAL RESEARCH REVIEW PROCESS, QUESTIONS ON THE PROTOCOL SUBMISSION FORM ARE DESIGNED TO ELICIT INFORMATION ABOUT POTENTIAL CONFLICTS. SITUATIONS IN WHICH A STAFF PARTICIPANT IN RESEARCH REPORTS A POTENTIAL CONFLICT ARE REFERRED TO THE CHAIR OF THE COIAC AND TO THE COMPLIANCE OFFICER FOR REVIEW. THE BOARD OF MEMORIAL SLOAN-KETTERING CANCER CENTER HAS MEMBERS THAT ACTIVELY SERVE AS OFFICERS AND/OR BOARD MEMBERS OF PUBLICLY-TRADED COMPANIES. THE INSTITUTION MAY PROCURE GOODS AND/OR SERVICES FROM THESE PUBLICLY TRADED COMPANIES THROUGH THE ORDINARY COURSE OF THE PROVIDER'S BUSINESS ON TERMS AND CONDITIONS WHICH ARE THE SAME THAT SUCH COMPANIES CHARGE TO THE GENERAL PUBLIC. ANY OF OUR BOARD MEMBERS THAT HAVE AN AFFILIATION WITH SUCH COMPANIES ARE NOT INVOLVED IN THE TRANSACTION, INCLUDING, WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, IN NEGOTIATING OR AFFECTING THE TERMS OF THE TRANSACTION. THE INSTITUTION HAS A COMPREHENSIVE CONFLICT OF INTEREST POLICY. REPORTABLE TRANSACTIONS IDENTIFIED THROUGH OUR ANNUAL CONFLICT OF INTEREST QUESTIONNAIRE ARE DISCLOSED ON SCHEDULE L. THESE TRANSACTIONS WERE ALSO CONSUMMATED ON AN ARM'S LENGTH BASIS BY MANAGEMENT OF THE INSTITUTION. MSKCC'S "POLICY ON CONFLICTS OF INTERESTS FOR DIRECTORS AND KEY EMPLOYEES" APPLIES TO ANY BOARD OF MANAGERS MEMBER, PRINCIPAL OFFICER, OR MEMBER OF A COMMITTEE WITH BOARD-DELEGATED POWERS. INDIVIDUALS COVERED BY THIS POLICY HAVE A DUTY TO DISCLOSE FINANCIAL INTERESTS, AS DEFINED BY THE POLICY, ANNUALLY AND AS THEY ARISE. IN THE EVENT A COVERED INDIVIDUAL IS INVOLVED IN A BOARD OR COMMITTEE ACTION (SUCH AS APPROVAL OF A TRANSACTION OR ARRANGEMENT) AND THE INDIVIDUAL HAS A FINANCIAL INTEREST RELATED TO THE MATTER BEFORE THE BOARD, THE INDIVIDUAL MUST DISCLOSE THE FINANCIAL INTEREST AND ALL MATERIAL FACTS TO THE BOARD OR COMMITTEE. THE INDIVIDUAL MUST LEAVE THE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON, AND THE REMAINING, DISINTERESTED BOARD OR COMMITTEE MEMBERS ARE RESPONSIBLE TO DECIDE IF A CONFLICT EXISTS. IF A DETERMINATION IS MADE THAT A CONFLICT EXISTS, THE INVOLVED INDIVIDUAL MAY MAKE A PRESENTATION TO THE BOARD OR COMMITTEE BUT S/HE MUST LEAVE THE MEETING DURING THE DISCUSSION OF AND THE VOTE ON THE TRANSACTION OR ARRANGEMENT. THE BOARD OR COMMITTEE IS REQUIRED TO DETERMINE WHETHER MSKCC CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS FROM AN UNCONFLICTED PERSON OR ENTITY. AS APPROPRIATE, THE CHAIRPERSON OF THE BOARD OR COMMITTEE IS RESPONSIBLE TO APPOINT A DISINTERESTED PERSON OR COMMITTEE TO INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. BOARD OR COMMITTEE IS REQUIRED TO DETERMINE WHETHER MSKCC CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR ARRANGEMENT WITH REASONABLE EFFORTS FROM AN UNCONFLICTED PERSON OR ENTITY. S/HE MUST LEAVE THE MEETING DURING THE DISCUSSION OF AND THE VOTE ON THE TRANSACTION OR ARRANGEMENT. PART VI, LINE 15 MEMORIAL SLOAN-KETTERING CANCER CENTER (MSKCC) IS COMMITTED TO ENSURING THAT ITS EXECUTIVE COMPENSATION PROGRAM ADHERES TO THE ESTABLISHED STANDARDS OF REGULATORY COMPLIANCE AND BEST CORPORATE GOVERNANCE. THE MSKCC BOARD OF OVERSEERS AND MANAGERS HAS CHARGED THE JOINT HUMAN RESOURCES COMMITTEE (WHICH IS COMPOSED ENTIRELY OF INDEPENDENT BOARD MEMBERS WITH NO CONFLICTS OF INTEREST IN REGARDS TO EXECUTIVE COMPENSATION) WITH MAKING ALL DECISIONS RELATED TO COMPENSATION FOR OFFICERS AND KEY EMPLOYEES. THE COMMITTEE REVIEWS THE TOTAL COMPENSATION OF THE INDIVIDUALS, INCLUDING BOTH CURRENT AND DEFERRED COMPENSATION, AND ALL EMPLOYEE BENEFITS, ON AN ANNUAL BASIS TO ENSURE THAT THE TOTAL COMPENSATION OF EACH OFFICER AND KEY EMPLOYEE IS REASONABLE. TO ASSIST IN THE COMPLETION OF ITS RESPONSIBILITIES, THE COMMITTEE ENGAGES THE SERVICES OF A NATIONALLY RECOGNIZED CONSULTING FIRM SPECIALIZING IN EXECUTIVE COMPENSATION FOR NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS. EACH YEAR THE COMMITTEE REVIEWS A COMPREHENSIVE REPORT PREPARED BY THE FIRM THAT INCLUDES MARKET DATA FOR FUNCTIONALLY COMPARABLE ROLES IN COMPARABLE ORGANIZATIONS (I.E., NOT-FOR-PROFIT ACADEMIC/RESEARCH MEDICAL CENTERS, ESPECIALLY THOSE SHARING A MISSION SIMILAR TO MSKCC, WITH OTHER HEALTHCARE SECTORS CONSIDERED ON A SELECTED BASIS) AND SUMMARIZES THE RELATIVE MARKET POSITION OF EACH EXECUTIVE'S TOTAL COMPENSATION. THE LAST REVIEW WAS DECEMBER 2016. THIS REVIEW SETS THE COMPENSATION FOR THE FOLLOWING YEAR. ADDITIONALLY, A SENIOR MEMBER OF THE CONSULTING FIRM ATTENDS THE COMMITTEE'S MEETINGS TO PROVIDE INFORMATION AND TO RESPOND TO QUESTIONS BY THE MEMBERS OF THE COMMITTEE. COMPENSATION LEVELS ARE ESTABLISHED CONSIDERING THE MARKET DATA, AN ASSESSMENT OF PERFORMANCE, AND OTHER BUSINESS JUDGMENT FACTORS, CONSISTENT WITH MSKCC'S EXECUTIVE COMPENSATION PHILOSOPHY. THE COMMITTEE'S DECISIONS ARE MADE IN THE BEST INTERESTS OF MSKCC, AND ARE INTENDED TO ENSURE THE RECRUITMENT AND RETENTION OF KEY EXECUTIVE TALENT, CONSISTENT WITH THE MARKET PRACTICES OF OTHER NOT-FOR-PROFIT HEALTHCARE ORGANIZATIONS OF COMPARABLE SCOPE, MISSION AND COMPLEXITY. ON AN ANNUAL BASIS, THE COMMITTEE PROVIDES THE FULL BOARD WITH AN OVERVIEW OF ITS DETERMINATIONS AND PROCESS. THE COMMITTEE'S REVIEW PROCESS FOLLOWS THE INTERMEDIATE SANCTIONS GUIDELINES FOR QUALIFYING FOR THE REBUTTABLE PRESUMPTION OF REASONABLENESS UNDER SECTION 4958 OF THE INTERNAL REVENUE CODE OF 1986: - THE COMPENSATION ARRANGEMENT IS APPROVED IN ADVANCE BY AN "AUTHORIZED BODY" OF THE APPLICABLE TAX EXEMPT ORGANIZATION (I.E, THE COMMITTEE, WHICH IS COMPOSED ENTIRELY OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITHIN THE MEANING OF THE REGULATIONS UNDER SECTION 4958). - THE AUTHORIZED BODY OBTAINS AND RELIES UPON "APPROPRIATE DATA AS TO COMPARABILITY" PRIOR TO MAKING ITS DETERMINATION, FOR WHICH COMPARABILITY DATA ARE PROVIDED AND ANALYZED BY SULLIVAN, COTTER AND ASSOCIATES, INC., A WELL-REGARDED EXPERT IN THE AREA OF HEALTHCARE COMPENSATION. - THE COMMITTEE ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION CONCURRENTLY WITH MAKING THAT DETERMINATION, AGAIN AS REQUIRED IN THE REGULATIONS. PART VI, LINE 19 OUR AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. IN ADDITION, THE FINANCIAL STATEMENTS CAN BE ACCESSED AT THE FOLLOWING WEB ADDRESS: WWW.DACBOND.COM. THE INSTITUTION HAS ENGAGED DAC BOND AS OUR INVESTOR RELATIONS AND DISCLOSURE/DISSEMINATION AGENT. THE INFORMATION AVAILABLE ON THIS WEB SITE INCLUDES AUDITED FINANCIAL STATEMENTS, QUARTERLY UNAUDITED FINANCIAL STATEMENTS AND THE BOND OFFERING STATEMENTS FOR ALL OUR DEBT ISSUES. IN ADDITION, COPIES OF THE GROUP 990 AND FILED 990T ARE ALSO AVAILABLE. THE CONFLICT OF INTEREST POLICY IS AVAILABLE TO THE PUBLIC UPON REQUEST AND IT ALSO CAN BE FOUND AT THE FOLLOWING INSTITUTIONAL WEB SITE: WWW.MSKCC.ORG. GOVERNING DOCUMENTS SUCH AS THE ARTICLES OF INCORPORATION AND CORPORATE BY-LAWS ARE NOT MADE AVAILABLE TO THE PUBLIC. PART VII, SECTION A THIS IRS FORM 990 IS FILED UNDER GROUP EXEMPTION NUMBER 3475, EIN 91-2154267. THE ATTACHED LIST REPRESENTS MEMBERS FROM THE GOVERNING BOARDS OF THE FOLLOWING AFFILIATED INSTITUTIONS THAT MAKE UP OUR EXEMPT GROUP: MEMORIAL SLOAN-KETTERING CANCER CENTER (MSK) EIN 13-1924236, MEMORIAL HOSPITAL FOR CANCER AND ALLIED DISEASES (MEM) EIN 13-1624082, SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (SKI) EIN 13-1624182, S.K.I. REALTY, INC. (SKR) EIN 13-3389586, LOUIS V. GERSTNER JR. GRADUATE SCHOOL OF BIOMEDICAL SCIENCES (SKG) EIN 20-2212588, MSK INSURANCE US, INC. (MVI) EIN 83-0363317, AND MSKCC PROTON INC.,(MPI) EIN 35-2397819. ALSO INCLUDED IN THE GROUP IS MSK PROPERTIES LLC. EIN 35-2464610 WITH MEMORIAL HOSPITAL BEING THE SOLE MEMBER. MEMORIAL SLOAN KETTERING CANCER CENTER BOARD OF MANAGERS RICHARD I. BEATTIE IAN COOK STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON, EFFECTIVE APRIL 2016 WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR. JONATHAN N. GRAYER BENJAMIN W. HEINEMAN, JR. DAVID H. KOCH MARIE-JOSEE KRAVIS JAMIE C. NICHOLLS, NOT INDEPENDENT SEE SCHEDULE L JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS, BOARD MEMBER & TREASURER ALEXANDER T. ROBERTSON, EFFECTIVE APRIL 2016 JAMES D. ROBINSON III, BOARD MEMBER & HONORARY CHAIRMAN OF THE BOARD VIRGINIA M. ROMETTY NORMAN C SELBY, BOARD MEMBER & SECRETARY STEPHEN C. SHERRILL LAVINIA BRANCA SNYDER PETER J. SOLOMON JOHN R. STRANGFELD, EFFECTIVE APRIL 2016 SCOTT M. STUART, VICE CHAIRMAN OF THE BOARD CRAIG B. THOMPSON, M.D., BOARD MEMBER, PRESIDENT AND CHIEF EXECUTIVE OFFICER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III, CHAIRMAN OF THE BOARD PETER A. WEINBERG DEBORAH C. WRIGHT 31 TOTAL BOARD MEMBERS 29 INDEPENDENT BOARD MEMBERS MEMORIAL HOSPITAL BOARD OF MANAGERS RICHARD I. BEATTIE, HONORARY CHAIRMAN OF THE BOARD IAN COOK STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON, EFFECTIVE APRIL 2016 WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR. JONATHAN N. GRAYER BENJAMIN W. HEINEMAN, JR. DAVID H. KOCH MARIE-JOSEE KRAVIS JAMIE C. NICHOLLS JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS, BOARD MEMBER & TREASURER ALEXANDER T. ROBERTSON, EFFECTIVE APRIL 2016 JAMES D. ROBINSON III VIRGINIA M. ROMETTY NORMAN C SELBY, BOARD MEMBER & SECRETARY, NOT INDEPENDENT SEE SCHEDULE L STEPHEN C. SHERRILL LAVINIA BRANCA SNYDER PETER J. SOLOMON JOHN R. STRANGFELD, EFFECTIVE APRIL 2016 SCOTT M. STUART, CHAIRMAN OF THE BOARD CRAIG B. THOMPSON, M.D., BOARD MEMBER, CHIEF EXECUTIVE OFFICER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III, CHAIRMAN OF THE BOARD PETER A. WEINBERG DEBORAH C. WRIGHT 31 TOTAL BOARD MEMBERS 29 INDEPENDENT BOARD MEMBERS SLOAN KETTERING INSTITUTE BOARD OF MANAGERS RICHARD I. BEATTIE IAN COOK STANLEY F. DRUCKENMILLER ANTHONY B. EVNIN ROGER W. FERGUSON, EFFECTIVE APRIL 2016 WILLIAM E. FORD RICHARD N. FOSTER STEPHEN FRIEDMAN ELLEN V. FUTTER LOUIS V. GERSTNER, JR., HONORARY CHAIRMAN OF THE BOARD JONATHAN N. GRAYER BENJAMIN W. HEINEMAN, JR. DAVID H. KOCH MARIE-JOSEE KRAVIS JAMIE C. NICHOLLS JAMES G. NIVEN BRUCE C. RATNER CLIFTON S. ROBBINS, BOARD MEMBER & TREASURER ALEXANDER T. ROBERTSON, EFFECTIVE APRIL 2016 JAMES D. ROBINSON III VIRGINIA M. ROMETTY NORMAN C SELBY, BOARD MEMBER & SECRETARY LAVINIA BRANCA SNYDER STEPHEN C. SHERRILL PETER J. SOLOMON JOHN R. STRANGFELD, EFFECTIVE APRIL 2016 SCOTT M. STUART CRAIG B. THOMPSON, M.D., BOARD MEMBER, CHIEF EXECUTIVE OFFICER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III DEBORAH C. WRIGHT 30 TOTAL BOARD MEMBERS 29 INDEPENDENT BOARD MEMBERS S.K.I. REALTY BOARD OF MANAGERS RICHARD I. BEATTIE LOUIS V. GERSTNER, JR. JAMES G. NIVEN, PRESIDENT CLIFTON S. ROBBINS SCOTT M. STUART DOUGLAS A. WARNER III, CHAIRMAN OF THE BOARD 6 TOTAL BOARD MEMBERS 6 INDEPENDENT BOARD MEMBERS GERSTNER GRADUATE SCHOOL BOARD OF MANAGERS RICHARD I. BEATTIE ELLEN V. FUTTER LOUIS V. GERSTNER, JR., CHAIRMAN OF THE BOARD DAVID H. KOCH MARIE-JOSSE KRAVIS CRAIG B. THOMPSON, M.D. BOARD MEMBER, PRESIDENT, EMPLOYEE, NOT INDEPENDENT BOARD MEMBER DOUGLAS A. WARNER III 7 TOTAL BOARD MEMBERS 6 INDEPENDENT BOARD MEMBERS MSK INSURANCE U.S. BAORD OF MANAGERS KATHRYN MARTIN, DIRECTOR AND SECRETARY, EMPLOYEE NOT AN INDEPENDENT BOARD MEMBER STEPHEN C. SHERRILL, CHAIRMAN OF THE BOARD MARK SVENNINGSON, BOARD MEMBER AND PRESIDENT EMPLOYEE, NOT INDEPENDENT BOARD MEMBER JEFFREY P. JOHNSON, BOARD MEMBER AND VICE PRESIDENT MICHAEL P. GUTNICK, BOARD MEMBER AND TREASURER EMPLOYEE, NOT INDEPENDENT BOARD MEMBER 5 TOTAL BOARD MEMBERS 2 INDEPENDENT BOARD MEMBERS MSKCC PROTON INC., BOARD OF MANAGERS JOSE BASELGA MD PHD, EMPLOYEE NOT AN INDEPENDENT DIRECTOR MICHAEL P. GUTNICK, EMPLOYEE NOT AN INDEPENDENT DIRECTOR SIMON NICHOLAS POWELL MD, EMPLOYEE NOT AN INDEPENDENT DIRECTOR 3 TOTAL DIRECTORS 0 INDEPENDENT DIRECTORS PART VII, SECTION B AMOUNTS PAID TO INDEPENDENT CONTRACTORS INCLUDE AMOUNTS PAID TO SUBCONTRACTORS AS WELL AS REIMBURSABLE EXPENSES. PART XI RECONCILIATION OF NET ASSETS, OTHER NON-OPERATING (EXPENSE): CHANGE IN POSTRETIREMENT $(30,222,000) INTEREST & COST OF ISSUANCE OF TAXABLE BONDS (37,863,899) CUNY RECEIVABLE WRITE OFF (11,089,440) 2006 SERIES I BOND DEFEASEMENT (1,256,198) OTHER (288,463) NET (EXPENSES) $(80,720,000) PROSTATE CANCER CLINICAL TRIALS 1275 YORK AVE NEW YORK NY 10065 352506225 CANCER CARE DE 4152000 1364000 MSKCC RALPH LAUREN CTR FOR CANCER & PREVENTION 1919 MADISON AVE NEW YORK NY 10036 020597827 CANCER CARE NY 501( C)3 10 MSKCC true MEMORIAL MEDICAL CARE PC 1275 YORK AVENUE NEW YORK NY 10065 352491455 CANCER CARE NY 501( C)3 10 MSKCC true BYRNE FD FBO MSKCC 3 LARMIE ROAD - BOX 599 ETNA NH 03750 020462932 SUPPORTING DE 501 (C) 3 12d III-0 NA false MEM CRITICAL CARE 1275 YORK AVE NY NY 10065 133348785 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM INFECT DISEASE 1275 YORK AVE NY NY 10065 133278582 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM MEDICAL CONSULT 1275 YORK AVE NY NY 10065 133278550 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NUTRITION GRP 1275 YORK AVE NY NY 10065 133278576 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM SOLID TUMOR GRP 1275 YORK AVE NY NY 10065 133278578 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PULMONARY FUNC 1275 YORK AVE NY NY 10065 133304834 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CARDIOPULMONARY 1275 YORK AVE NY NY 10065 133278552 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK RADIOLOGY GRP 1275 YORK AVE NY NY 10065 133375559 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NUCLEAR MED 1275 YORK AVE NY NY 10065 133278580 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM RADIATION ONCOL 1275 YORK AVE NY NY 10065 133237927 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PATHOLOGY GRP 1275 YORK AVE NY NY 10065 133365998 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ANESTHESIOLOGY 1275 YORK AVE NY NY 10065 133367135 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PEDIATRICS GRP 1275 YORK AVE NY NY 10065 133346908 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROLOGY GRP 1275 YORK AVE NY NY 10065 133399377 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PSYCHIATRY GRP 1275 YORK AVE NY NY 10065 133430629 HEALTH CARE NY MEM related 0 0 false 0 true 1.00000 MSK AT GUTTMAN 1275 YORK AVE NY NY 10065 133875002 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK PHYS AT PHELPS 1275 YORK AVE NY NY 10065 133897156 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK AT MERCY 1275 YORK AVE NY NY 10065 133954858 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK PHYS-ST CLARE'S 1275 YORK AVE NY NY 10065 133897154 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK REHABILITATION 1275 YORK AVE NY NY 10065 134010371 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK SURGERY GROUP 1275 YORK AVE NY NY 10065 134010372 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK HAUPPAUGE 1275 YORK AVE NY NY 10065 134059247 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROSURGERY 1275 YORK AVE NY NY 10065 133251621 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 INTERGRATIVE MED 1275 YORK AVE NY NY 10065 542092060 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK-REGIONAL NETWK 1275 YORK AVE NY NY 10065 020594889 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK BASKING RIDGE 1275 YORK AVE NY NY 10065 593801080 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM URGENT CARE GRP 1275 YORK AVE NY NY 10065 651263291 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLN GENETICS 1275 YORK AVE NY NY 10065 651263292 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DEVELOP CHEMO 1275 YORK AVE NY NY 10065 133278548 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MSK CLINIC PRACTICE 1275 YORK AVE NY NY 10065 510616510 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM BREAST GROUP 1275 YORK AVE NY NY 10065 562568640 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM COLORECTAL GRP 1275 YORK AVE NY NY 10065 562568642 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DENTAL GRP 1275 YORK AVE NY NY 10065 562568630 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLINICAL IMMUNO 1275 YORK AVE NY NY 10065 133278559 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM GASTRIC MIX TMR 1275 YORK AVE NY NY 10065 562568650 HEALTH CARE NY MEM related 0 0 false 0 true 1.00000 MEM GYNECOLOGY GRP 1275 YORK AVE NY NY 10065 562568655 HEALTH CARE NY MEM related 0 0 false 0 true 1.00000 MEM HEAD & NECK GRP 1275 YORK AVE NY NY 10065 562568656 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEPATOBILIARY 1275 YORK AVE NY NY 10065 562568667 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM NEUROSURGERY 1275 YORK AVE NY NY 10065 562568663 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPT ABRAMSON 1275 YORK AVE NY NY 10065 562568627 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPTHALMIC ONOCO 1275 YORK AVE NY NY 10065 562568675 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM OPHTHALMOLOGY 1275 YORK AVE NY NY 10065 562568669 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ORTHOPEDIC GRP 1275 YORK AVE NY NY 10065 562568680 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PEDIATRIC SURG 1275 YORK AVE NY NY 10065 562568683 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM CLINICAL PHY 1275 YORK AVE NY NY 10065 133278556 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PLASTIC RECON 1275 YORK AVE NY NY 10065 562568623 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM THORACIC GRP 1275 YORK AVE NY NY 10065 562568677 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM UROLOGY GRP 1275 YORK AVE NY NY 10065 562568638 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM PAIN SERVICE 1275 YORK AVE NY NY 10065 651283822 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM DERMATOLOGY GRP 1275 YORK AVE NY NY 10065 133278581 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM ENDOCRINE GRP 1275 YORK AVE NY NY 10065 133278583 HEALTH CARE NY MEM related 0 0 false 0 true 1.00000 GASTROENTEROLOGY 1275 YORK AVE NY NY 10065 133278574 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 MEM HEMATOLOGYLYMP 1275 YORK AVE NY NY 10065 133278575 HEALTH CARE NY MEM RELATED 0 0 false 0 true 1.00000 CHARITABLE REMAINDER TRUSTS 178 false true false false false false false false true true true true false false false true false false RALPH LAUREN CTR FOR CANCER & PREVENTION Q 2573209 COST RALPH LAUREN CTR FOR CANCER & PREVENTION B 1100000 COST MEMORIAL MEDICAL CARE PC Q 74024 COST